6,075 results on '"Saxena A"'
Search Results
2. Current state of non-hematologic cancer-associated thrombosis at a tertiary care hospital in India
- Author
-
Seema Tyagi, Amrita Ramaswami, Renu Saxena, Mukul Aggarwal, and Manoranjan Mahapatra
- Subjects
medicine.medical_specialty ,Referral ,business.industry ,Genitourinary system ,Hematology ,Heparin ,medicine.disease ,Malignancy ,Thrombosis ,Quality of life ,Internal medicine ,Epidemiology ,medicine ,Immunology and Allergy ,Adenocarcinoma ,business ,medicine.drug - Abstract
Introduction Cancer-associated thrombosis is a leading cause of morbidity and mortality in malignancy patients. Prophylactic anticoagulation is under-utilized and the cost of low-molecular-weight heparin (LMWH) and direct oral anticoagulants is a major barrier in developing countries. Material and methods A retrospective analysis was performed of all cancer-associated thrombosis patients attending the thrombosis clinic at a tertiary-level referral hospital based in North India between 2011 and 2015. Patient demographics and disease-related parameters were collected and analyzed. Results A total of 771 patients attended the thrombosis clinic during study period, of which 64 cases were malignancy-associated. Of these, 56% of the patients were female and 20% were bedridden. The median age was 48.5 years, adenocarcinoma (48%) being the most common histological subtype. Gynecological malignancies (30%) were the most common malignancies, followed by genitourinary (11%) malignancies. Most of the cases occurred during first year of diagnosis (51%), and only 14% occurred after 3 years. Most of the patients were on combined treatment. Almost 40% of the patients developed thrombosis within 30 days of surgical treatment. Lower limb thrombosis was the most commonly seen type (56%), while abdominal and pulmonary thrombosis were both seen in 5%. Patients were managed with LMWH and vitamin K antagonists (84.3%) and only 6.25% with LMWH alone. Direct oral anticoagulants were not commonly used during the study period. Discussion At the hospital studied, most of the cases occurred early in the disease course. Postoperative prophylaxis could have contributed towards reducing thrombosis in the peri-operative period. Early suspicion and prompt treatment can improve quality of life in such patients.
- Published
- 2023
3. Natural Inhibitors against Potential Targets of Cyclooxygenase, Lipoxygenase and Leukotrienes
- Author
-
Sisir Nandi, Sudatta Dey, Rishita Dey, Asmita Samadder, and Anil Saxena
- Subjects
Pain ,Inflammation ,Osteoarthritis ,Pharmacology ,chemistry.chemical_compound ,Lipoxygenase ,Drug Discovery ,medicine ,Humans ,Pain Management ,Cyclooxygenase Inhibitors ,Lipoxygenase Inhibitors ,biology ,business.industry ,Anti-Inflammatory Agents, Non-Steroidal ,Organic Chemistry ,Cancer ,General Medicine ,medicine.disease ,Computer Science Applications ,chemistry ,Rheumatoid arthritis ,Toxicity ,biology.protein ,Leukotriene Antagonists ,Arachidonic acid ,Cyclooxygenase ,medicine.symptom ,business - Abstract
Background: Cyclooxygenase (COX) and Lipoxygenase (LOX) enzymes catalyze the production of pain mediators like Prostaglandins (PGs) and Leukotrienes (LTs), respectively from arachidonic acid. Introduction: The COX and LOX enzyme modulators are responsible for the major PGs and LTs mediated complications like asthma, osteoarthritis, rheumatoid arthritis, cancer, Alzheimer’s disease, neuropathy and Cardiovascular Syndromes (CVS). Many synthetic Nonsteroidal Anti- Inflammatory Drugs (NSAIDs) used in the treatment have serious side effects like nausea, vomiting, hyperacidity, gastrointestinal ulcers, CVS, etc. Methods: The natural inhibitors of pain mediators have great acceptance worldwide due to fewer side effects on long-term uses. The present review is an extensive study of the advantages of plantbased vs synthetic inhibitors. Results: These natural COX and LOX inhibitors control inflammatory response without causing side-effect-related complicacy. Conclusion: Therefore, the natural COX and LOX inhibitors may be used as alternative medicines for the management of pain and inflammation due to their less toxicity and resistivity.
- Published
- 2022
4. Outcomes after perioperative SARS-CoV-2 infection in patients with proximal femoral fractures: an international cohort study
- Author
-
Khatri, C, Ward, AE, Nepogodiev, D, Ahmed, I, Chaudhry, D, Dhaif, F, Bankhad-Kendall, B, Kaafarani, H, Bretherton, C, Mahmood, A, Marais, L, Parsons, N, Bhangu, A, Metcalfe, A, Siaw-Acheampong, K, Dawson, BE, Evans, JP, Glasbey, JC, Gujjuri, RR, Heritage, E, Jones, CS, Kamarajah, SK, Keatley, JM, Lawday, S, Li, E, Mckay, SC, Pellino, G, Tiwari, A, Simoes, JFF, Trout, IM, Venn, ML, Wilkin, RJW, Ademuyiwa, AO, Agarwal, A, Al Ameer, E, Alderson, D, Alser, O, Arnaud, AP, Augestad, KM, Bankhead-Kendall, B, Benson, RA, Chakrabortee, S, Blanco-Colino, R, Brar, A, Bravo, A Minaya, Breen, KA, Buarque, I Lima, Caruana, E, Cunha, MF, Davidson, GH, Desai, A, Di Saverio, S, Edwards, J, Elhadi, M, Farik, S, Fiore, M, Fitzgerald, JE, Ford, S, Gallo, G, Ghosh, D, Gomes, GMA, Griffiths, E, Halkias, C, Harrison, EM, Hutchinson, P, Isik, A, Kolias, A, Lawani, I, Lederhuber, H, Leventoglu, S, Loffler, MW, Martin, J, Mashbari, H, Mazingi, D, Mohan, H, Moore, R, Moszkowicz, D, Ng-Kamstra, JS, Metallidis, S, Moug, S, Niquen, M, Ntirenganya, F, Outani, O, Pata, F, Pinkney, TD, Pockney, P, Radenkovic, D, Ramos-De la Medina, A, Roberts, K, Santos, I, Schache, A, Schnitzbauer, A, Stewart, GD, Shaw, R, Shu, S, Soreide, K, Spinelli, A, Sundar, S, Tabiri, S, Townend, P, Tsoulfas, G, van Ramshorst, G, Vidya, R, Vimalachandran, D, Wright, N, Mak, JKC, Kulkarni, R, Sharma, N, Nankivell, P, Tirotta, F, Parente, A, Breik, O, Kisiel, A, Cato, LD, Saeed, S, Pathanki, AM, Almond, M, Kamal, M, Chebaro, A, Lecolle, K, Truant, S, El Amrani, M, Zerbib, P, Pruvot, FR, Mathieu, D, Surmei, E, Mattei, L, Marin, H, Dudek, J, Singhal, T, El-Hasani, S, Nehra, D, Walters, A, Cuschieri, J, Ho, M, Wade, RG, Johnstone, J, Bourke, G, Brunelli, A, Elkadi, H, Otify, M, Pompili, C, Burke, JR, Bagouri, E, Chowdhury, M, Abual-Rub, Z, Kaufmann, A, Munot, S, Lo, T, Young, A, Kowal, M, Wall, J, Peckham-Cooper, A, Winter, SC, Belcher, E, Stavroulias, D, Di Chiara, F, Wallwork, K, Qureishi, A, Lami, M, Sravanam, S, Mastoridis, S, Shah, K, Chidambaram, S, Smillie, R, Shaw, AV, Bandyopadhyay, S, Cernei, C, Jeyaretna, D, Ganau, M, Piper, RJ, Duck, E, Brown, S, Jelley, C, Tucker, SC, Bond-Smith, G, Griffin, XL, Tebala, GD, Neal, N, Vatish, M, Noton, TM, Ghattaura, H, Maher, M, Fu, H, Risk, OBF, Majd, Soleymani H, Sinha, S, Shankar, S, Aggarwal, A, Kharkar, H, Lakhoo, K, Verberne, C, Senent-Boza, A, Sanchez-Arteaga, A, Benitez-Linero, I, Manresa-Manresa, F, Tallon-Aguilar, L, Melero-Cortes, L, Fernandez-Marin, MR, Duran-Munoz-Cruzado, VM, Ramallo-Solis, I, Beltran-Miranda, P, Pareja-Ciuro, F, Anton-Eguia, BT, Dawson, AC, Drane, A, Oliva Mompean, F, Gomez-Rosado, J, Reguera-Rosal, J, Valdes-Hernandez, J, Capitan-Morales, L, del Toro Lopez, MD, Patel, M, Shabana, A, Alanbuki, A, Usman, O, Tang, A, Beamish, AJ, Price, C, Bosanquet, D, Magowan, D, Solari, F, Williams, G, Nassa, H, Smith, L, Elliott, L, Mccabe, G, Holroyd, D, Jamieson, NB, Mariani, NM, Nicastro, V, Li, Z, Parkins, K, Spencer, N, Harries, R, Egan, RJ, Motter, D, Jenvey, C, Mahoney, R, Fine, N, Minto, T, Henry, A, Gill, C, Dunne, N, Sarma, DR, Godbole, C, Carlos, W, Tewari, N, Jeevan, D, Naredla, P, Khajuria, A, Connolly, H, Robertson, S, Sweeney, C, Di Taranto, G, Shanbhag, S, Dickson, K, McEvoy, K, Skillman, J, Sait, M, Al-omishy, H, Baig, M, Heer, B, Lunevicius, R, Sheel, ARG, Sundhu, M, Santini, AJA, Fathelbab, MSAT, Hussein, KMA, Nunes, QM, Jones, RP, Shahzad, K, Haq, I, Baig, MMAS, Hughes, JL, Kattakayam, A, Rajput, K, Misra, N, Shah, SB, Clynch, AL, Georgopoulou, N, Sharples, HM, Apampa, AA, Nzenwa, IC, Sud, A, Podolsky, D, Coleman, NL, Callahan, MP, Dunstan, M, Beak, P, Gerogiannis, I, Ebrahim, A, Alwadiya, A, Goyal, A, Phillips, A, Bhalla, A, Demetriou, C, Grimley, E, Theophilidou, E, Ogden, E, Malcolm, FL, Davies-Jones, G, Ng, JCK, Mirza, M, Hassan, M, Elmaleh, N, Daliya, P, Williams, S, Bateman, A, Chia, Z, A'Court, J, Konarski, A, Faulkner, G, Talwar, R, Patel, K, Askari, A, Jambulingam, PS, Shaw, S, Maity, A, Hatzantonis, C, Sagar, J, Kudchadkar, S, Cirocchi, N, Chan, CH, Eberbach, H, Bayer, J, Erdle, B, Sandkamp, R, Breen, K, Velmahos, G, Maurer, LR, El Moheb, M, Gaitanidis, A, Naar, L, Christensen, MA, Kapoen, C, Langeveld, K, El Hechi, M, Mokhtari, A, Main, B, Maccabe, T, Newton, C, Blencowe, NS, Fudulu, DP, Bhojwani, D, Baquedano, M, Caputo, M, Rapetto, F, Flannery, O, Hassan, A, Ward, A, Tadross, D, Majkowski, L, Blundell, C, Forlani, S, Nair, R, Guha, S, Brown, SR, Steele, C, Kelty, CJ, Newman, T, Lee, M, Chetty, G, Lye, G, Balasubramanian, SP, Shah, Sureshkumar N, Sherif, M, Al-mukhtar, A, Whitehall, E, Giblin, A, Wells, F, Sharkey, A, Adamec, A, Madan, S, Konsten, J, Van Heinsbergen, M, Sou, A, Simpson, D, Hamilton, E, Blair, J, Jimeno Fraile, J, Morales-Garcia, D, Carrillo-Rivas, M, Toledo Martinez, E, Pascual, A, Landaluce-Olavarria, A, Gonzalez De Miguel, M, Gomez Cruzado, Fernandez L, Begona, E, Lecumberri, D, Calvo Rey, A, Prada Hervella, GM, Dos Santos Carregal, L, Rodriguez, Fernandez MI, Freijeiro, M, El Drubi Vega, S, Van den Eynde, J, Oosterlinck, W, Van den Eynde, R, Sermon, A, Boeckxstaens, A, Cordonnier, A, De Coster, J, Jaekers, J, Politis, C, Miserez, M, Galipienso Eri, M, Garcia Montesino, JD, Dellonder Frigole, J, Noriego Munoz, D, Lizzi, V, Vovola, F, Arminio, A, Cotoia, A, Sarni, AL, Bekheit, M, Kamera, BS, Elhusseini, M, Sharma, P, Ahmeidat, A, Gradinariu, G, Cymes, W, Hannah, A, Mignot, G, Shaikh, S, Agilinko, J, Sgro, A, Rashid, MM, Milne, K, McIntyre, J, Akhtar, MA, Turnbull, A, Brunt, A, Stewart, KE, Wilson, MSJ, Rutherford, D, McGivern, K, Massie, E, Duff, S, Moura, F, Brown, BC, Khan, A, Asaad, P, Wadham, B, Aneke, IA, Collis, J, Warburton, H, Thomas, M, Pearce, L, Fountain, DM, Laurente, R, Sigamoney, KV, Dasa, M, George, K, Naqui, Z, Galhoum, M, Lipede, C, Gabr, A, Radhakrishnan, A, Hasan, MT, Kalenderov, R, Pathmanaban, O, Colombo, F, Chelva, R, Subba, K, Abou-Foul, AK, Khalefa, M, Hossain, F, Moores, T, Pickering, L, Shah, J, Anthoney, J, Emmerson, O, Bevan, K, Makin-Taylor, R, Ong, CS, Callan, R, Bloom, O, Chauhan, G, Kaur, J, Burahee, A, Bleibleh, S, Pigadas, N, Snee, D, Bhasin, S, Crichton, A, Habeebullah, A, Bodla, AS, Yassin, N, Mondragon, M, Dewan, V, Giuffrida, MC, Marano, A, Palagi, S, Grimaldi, Di Maria S, Testa, V, Peluso, C, Borghi, F, Simonato, A, Puppo, A, D'Agruma, M, Chiarpenello, R, Pellegrino, L, Maione, F, Cianflocca, D, Pruiti, Ciarello V, Giraudo, G, Gelarda, E, Dalmasso, E, Abrate, A, Daniele, A, Ciriello, V, Rosato, F, Garnero, A, Leotta, L, Chiozza, M, Anania, G, Urbani, A, Radica, Koleva M, Carcoforo, P, Portinari, M, Sibilla, M, Archer, JE, Odeh, A, Siddaiah, N, Baumber, R, Parry, J, Carmichael, H, Velopulos, CG, Wright, FL, Urban, S, McIntyre, Jr RC, Schroeppel, TJ, Hennessy, EA, Dunn, J, Zier, L, Parmar, C, Mccluney, S, Shah, S, Munoz Vives, JM, Osorio, A, Gomez Diaz, CJ, Guariglia, CA, Soto Montesinos, C, Sanchon, L, Xicola Martinez, M, Guardia, N, Collera, P, Diaz Del Gobbo, R, Sanchez Jimenez, R, Farre Font, R, Flores Clotet, R, Brathwaite, CEM, Liu, H, Petrone, P, Hakmi, H, Sohail, AH, Baltazar, G, Heckburn, R, Aujayeb, A, Townshend, D, McLarty, N, Shenfine, A, Jackson, K, Johnson, C, Madhvani, K, Hampton, M, Hormis, AP, Young, R, Miu, V, Sheridan, K, MacDonald, L, Green, S, Onos, L, Dean, B, Luney, C, Myatt, R, Williams, MA, McVeigh, J, Alqallaf, A, Ben-Sassi, A, Mohamed, I, Mellor, K, Joshi, P, Joshi, Y, Crichton, R, Sonksen, J, Aldridge, K, Layton, GR, Karki, B, Jeong, H, Pankhania, S, Asher, S, Folorunso, A, Mistry, S, Singh, B, Winyard, J, Mangwani, J, Babu, BHB, Liyanage, ASD, Newman, S, Blake, I, Weerasinghe, C, Ballabio, M, Bisagni, P, Longhi, M, Armao, T, Madonini, M, Gagliano, A, Pizzini, P, Alga, A, Nordberg, M, Sandblom, G, Jallad, S, Lord, J, Anderson, C, El Kafsi, J, Logishetty, K, Saadya, A, Midha, R, Ip, M, Ponniah, Subbiah H, Stockdale, T, Bacarese-Hamilton, T, Foster, L, James, A, Anjarwalla, N, Henriques, Marujo D, Hettige, R, Baban, C, Tenovici, A, Salerno, G, Hardie, J, Page, S, Anazor, F, King, SD, Luck, J, Kazzaz, S, HKruijff, S, De Vries, JPPM, Steinkamp, PJ, Jonker, PKC, Van der Plas, WY, Bierman, W, Janssen, Y, Borgstein, ABJ, Gisbertz, SS, Henegouwen, van Berge MI, Enjuto, D, Perez Gonzalez, M, Diaz Pena, P, Gonzalez, J, Marqueta De Salas, M, Martinez Pascual, P, Rodriguez Gomez, L, Garces Garcia, R, Ramos Bonilla, A, Herrera-Merino, N, Fernandez Bernabe, P, Cagigal Ortega, EP, Hernandez, I, de Castro Rubio, Garcia E, Cervera, I, Kashora, F, Siddique, MH, Singh, A, Barmpagianni, C, Basgaran, A, Basha, A, Okechukwu, V, Bartsch, A, Gallagher, P, Maqsood, A, Sahnan, K, Leo, CA, Lewis, SE, Ubhi, HK, Exley, R, Khan, U, Shah, P, Saxena, S, Zafar, N, Abdul-Jabar, H, Mongelli, F, Bernasconi, M, Di Giuseppe, M, Christoforidis, D, La Regina, D, Arigoni, M, Liew, I, Al-Sukaini, A, Mediratta, S, Saxena, D, Brown, O, Boal, M, Dean, H, Higgs, S, Stanger, S, Abdalaziz, H, Constable, J, Ishii, H, Preece, R, Dovell, G, Reddy, Gopi R, Dehal, A, Shah, HB, Cross, GWV, Seyed-Safi, P, Smart, YW, Kuc, A, Al-Yaseen, M, Jayasankar, B, Balasubramaniam, D, Abdelsaid, K, Mundkur, N, Gallagher, B, Hine, T, Keeler, B, Soulsby, RE, Taylor, A, Davies, E, Ryska, O, Raymond, T, Rogers, S, Tong, A, Hawkin, P, Kinnaman, G, Meagher, A, Sharma, I, Holler, E, Dunning, J, Viswanath, Y, Freystaetter, K, Dixon, J, Hadfield, JN, Hilley, A, Egglestone, A, Smith, B, Arkani, S, Freedman, J, Youssef, M, Sreedharan, L, Baskaran, D, Shaikh, I, Seebah, K, Reid, J, Watts, D, Kouritas, V, Chrastek, D, Maryan, G, Gill, DF, Khatun, F, Ranjit, S, Parakh, J, Sarodaya, V, Daadipour, A, Khalifa, M, Bosch, KD, Bashkirova, V, Dvorkin, LS, Kalidindi, VK, Choudhry, A, Marx, W, Espino Segura-Illa, M, Sanchez Aniceto, G, Castano-Leon, AM, Jimenez-Roldan, L, Delgado Fernandez, J, Perez Nunez, A, Lagares, A, Garcia Perez, D, Santas, M, Paredes, I, Esteban Sinovas, O, Moreno-Gomez, L, Rubio, E, Vega, V, Vivas Lopez, A, Labalde Martinez, M, Garcia Villar, O, Pelaez Torres, PM, Garcia-Borda, J, Ferrero Herrero, E, Gomez, P, Eiriz Fernandez, C, Ojeda-Thies, C, Pardo Garcia, JM, Jones, Wynn H, Divecha, H, Whelton, C, Board, T, Hardie, C, Powell-Smith, E, Alotaibi, M, Maashi, A, Zowgar, A, Alsakkaf, M, Izquierdo, O, Ventura, D, Castellanos, J, Lara, A, Escobar, D, Arrieta, M, Garcia de Cortazar, U, Villamor Garcia, I, Cioci, A, Ruiz, G, Allen, M, Rakoczy, K, Pavlis, W, Saberi, R, Sobti, A, Khaleel, A, Unnithan, A, Memon, K, Bhaskar, Pala RR, Maqboul, F, Kamel, F, Al-Samaraee, A, Madani, R, Kumar, L, Nisar, P, Agrawal, S, Llaquet Bayo, H, Duchateau, N, De Gheldere, C, Cheng, D, Yang, H, Fayad, A, Wood, ML, Persad, A, Groot, G, Pham, H, Hakami, I, Boeker, C, Mall, J, Smith, H, Haugstvedt, AF, Jonsson, M, Caja Vivancos, P, Villalabeitia Ateca, I, Prieto Calvo, M, Martin Playa, P, Gainza, A, Aragon Achig, EJ, Rodriguez Fraga, A, Melchor Corcostegui, I, Mallabiabarrena Ormaechea, G, Garcia Gutierrez, JJ, Barbier, L, Pesantez Peralta, MA, Jimenez Jimenez, M, Municio Martin, JA, Gomez Suarez, J, Garcia Opere, G, Pascua Gomez, LA, Onate Aguirre, M, Fernandez-Colorado, A, De la Rosa-Estadella, M, Gasulla-Rodriguez, A, Serrano-Martin, M, Peig-Font, A, Junca-Marti, S, Juarez-Pomes, M, Garrido-Ondono, S, Blasco-Torres, L, Molina-Corbacho, M, Maldonado-Sotoca, Y, Gasset-Teixidor, A, Blasco-Moreu, J, Turrado-Rodriguez, V, Lacy, AM, de Lacy, FB, Morales, X, Carreras-Castaner, A, Torner, P, Jornet-Gibert, M, Balaguer-Castro, M, Renau-Cerrillo, M, Camacho-Carrasco, P, Vives-Barquiel, M, Campuzano-Bitterling, B, Gracia, I, Pujol-Muncunill, R, Estaire Gomez, M, Padilla-Valverde, D, Sanchez-Garcia, S, Sanchez-Pelaez, D, Jimenez Higuera, E, Picon Rodriguez, R, Fernandez Camunas, A, Martinez-Pinedo, C, Garcia Santos, EP, Munoz-Atienza, V, Moreno Perez, A, de la Manzanara Cano, Lopez CA, Crego-Vita, D, Huecas-Martinez, M, Domenech, J, Rosello Anon, A, Sanguesa, MJ, Bernal-Sprekelsen, JC, Catala Bauset, JC, Renovell Ferrer, P, Martinez Perez, C, Gil-Albarova, O, Gilabert Estelles, J, Aghababyan, K, Rivas, R, Rivas, F, Escartin, J, Blas Laina, JL, Nogues, A, Cros, B, Talal El-Abur, I, Garcia Egea, J, Yanez, C, Kauppila, JH, Sarjanoja, E, Tzedakis, S, Bouche, PA, Gaujoux, S, Gossot, D, Seguin-Givelet, A, Fuks, D, Grigoroiu, M, Salas, Sanchez R, Cathelineau, X, Macek, P, Barbe, Y, Rozet, F, Barret, E, Mombet, A, Cathala, N, Brian, E, Zadegan, F, Conso, C, Baldwin, AJ, West, R, Gammeri, E, Catton, A, Kouris, Marinos S, Pereca, J, Singh, J, Patel, P, Handa, S, Kaushal, M, Kler, A, Reghuram, V, Tezas, S, Oktseloglou, V, Mosley, F, Monroy, De La Cruz MFI, Bobak, P, Omar, I, Ahad, S, Langlands, F, Brown, V, Hashem, M, Williams, A, Ridgway, A, Pournaras, D, Britton, E, Lostis, E, Ambler, GK, Chu, H, Hopkins, J, Manara, J, Chan, M, Doe, M, Moon, RDC, Jichi, T, Singleton, W, Mannion, R, Ramzi, J, Mohan, M, Singh, AA, Ashcroft, J, Baker, OJ, Coughlin, P, Davies, RJ, Durst, AZED, Abood, A, Habeeb, A, Hudson, VE, Lamb, B, Luke, L, Mitrasinovic, S, Murphy, S, Ngu, AWT, O'Neill, JR, Waseem, S, Wong, K, Georgiades, F, Hutchinson, PJ, Tan, XS, Pushpa-rajah, J, Colquhoun, A, Masterson, L, Abu-Nayla, I, Walker, C, Balakrishnan, A, Rooney, S, Irune, E, Byrne, MHV, Durrani, A, Richards, T, Venkatesan, Sethuraman A, Combellack, T, Williams, J, Tahhan, G, Mohammed, M, Kornaszewska, M, Valtzoglou, V, Deglurkar, I, Rahman, M, Von Oppell, U, Mehta, D, Koutentakis, M, Chek, Syed Nong SAH, Hill, G, Morris, C, Shinkwin, M, Torkington, J, Cornish, J, Houston, R, Mannan, S, Ayeni, F, Tustin, H, Bordenave, M, Robson, A, Manu, N, Eardley, N, Krishnan, E, Serevina, OL, Martin, E, Smith, C, Jones, A, Mahapatra, Roy S, Clifford, R, Matthews, W, Mohankumar, K, Khawaja, I, Palepa, A, Doulias, T, Premakumar, Y, Jauhari, Y, Koshnow, Z, Bowen, D, Uberai, A, Hirri, F, Stubbs, BM, McDonald, C, Manickavasagam, J, Ragupathy, K, Davison, S, Dalgleish, S, McGrath, N, Kanitkar, R, Payne, CJ, Ramsay, L, Ng, CE, Collier, T, Khan, K, Evans, R, Brennan, C, Henshall, DE, Drake, T, Zamvar, V, Tambyraja, A, Skipworth, RJE, Linder, G, McGregor, R, Brennan, P, Mayes, J, Ross, L, Smith, S, White, T, Jamjoom, AAB, Pasricha, R, Holme, T, Abbott, S, Razik, A, Thrumurthy, S, Steinke, J, Baker, M, Howden, D, Baxter, Z, Osagie, L, Bence, M, Fowler, GE, Massey, L, Rajaretnam, N, Evans, J, John, J, Goubran, A, Campain, N, McDermott, FD, McGrath, JS, Ng, M, Pascoe, J, Phillips, JRA, Daniels, IR, Raptis, DA, Pollok, JM, Machairas, N, Davidson, B, Fusai, G, Soggiu, F, Xyda, S, Salinas, Hidalgo C, Tzerbinis, H, Pissanou, T, Gilliland, J, Chowdhury, S, Varcada, M, Hart, C, Mirnezami, R, Knowles, J, Angamuthu, N, Vijay, V, Shakir, T, Hasan, R, Tansey, R, Ross, E, Loubani, M, Wilkins, A, Cao, H, Capitelli-McMahon, H, Hitchman, L, Ikram, H, Andronic, A, Ibrahim, Aboelkassem A, Totty, J, Tayeh, S, Chase, T, Humphreys, L, Ayorinde, J, Ghanbari, A, Cuming, T, Williams, K, Chung, E, Hagger, R, Karim, A, Hainsworth, A, Flatman, M, Trompeter, A, Hing, C, Tsinaslanidis, P, Benjamin, MW, Leyte, A, Tan, C, Smelt, J, Vaughan, P, Santhirakumaran, G, Hunt, I, Raza, M, Labib, A, Luo, X, Sudarsanam, A, Rolls, A, Lyons, O, Onida, S, Shalhoub, J, Sugand, K, Park, C, Sarraf, KM, Erridge, S, Kinross, J, Denning, M, Yalamanchili, S, Abuown, A, Ibrahim, M, Martin, G, Davenport, D, Wheatstone, S, Andreani, SM, Bath, MF, Sahni, A, Judkins, N, Springford, Rigueros L, Sohrabi, C, Bacarese-Hamilton, J, Taylor, FG, Patki, P, Tanabalan, C, Reynolds, J, Alexander, ME, Smart, CJ, Stylianides, N, Abdalla, M, Newton, K, Bhatia, K, Edmondson, R, Abdeh, L, Jones, D, Zeiton, M, Ismail, O, Naseem, H, Advani, R, Fell, A, Smith, A, Nikolaou, S, English, C, Kristinsson, S, Oni, T, Ilahi, N, Ballantyne, K, Woodward, Z, Merh, R, Robertson-Smith, B, Mahmoud, A, Ameerally, P, Finch, JG, Gnanachandran, C, Pop, I, Rogers, M, Yousef, Y, Woods, R, Zahid, H, Mundy, G, Dass, D, Ford, D, Khan, J, Thiruchandran, G, Toh, SKC, Ahmad, Y, Allana, A, Bellis, C, Babawale, O, Phan, YC, Lokman, U, Ismail, M, Koc, T, Witek, A, Duggleby, L, Shamoon, S, Stefan, S, Clancy, H, Singh, S, Mukherjee, S, Ferguson, D, Mansuri, A, Thakrar, A, Wickramarachchi, L, Cuthbert, R, Sivayoganathan, S, Chui, K, Karam, E, Dott, C, Singh, R, Lane, J, Colvin, HV, Badran, A, Cadersa, A, Cumpstey, A, Hamady, Z, Aftab, R, Wensley, F, Byrne, J, Morrison-Jones, V, Sekhon, GK, Shields, H, Shakoor, Z, Yener, A, Talbot, T, Alzetani, A, Cresner, R, Johnson, D, Hughes, I, Hall, J, Rooney, J, Chatterji, S, Zhang, Y, Owen, R, Rudic, M, Hunt, J, Zakai, D, Aladeojebi, A, Ali, M, Gaunt, A, Barmayehvar, B, Kitchen, M, Gowda, M, Mansour, F, Jarvis, M, Halliday, E, Lefroy, R, Nanjaiah, P, Ali, S, Lin, DJ, Rajgor, AD, Scurrah, RJ, Kang, C, Watson, LJ, Harris, G, Royle, T, Cunningham, Y, James, G, Steel, B, Luk, ACO, Stables, G, Doorgakant, A, Thiruvasagam, VG, Carter, J, Reid, S, Mohammed, R, Marlow, W, Ferguson, H, Wilkin, R, Konstantinou, C, Yershov, D, Vatish, J, Denning, A, Das, R, Powell, S, Magee, C, Agarwal, K, Mangos, E, Nambirajan, T, Flindall, I, Mahendran, V, Hanson, A, De Marchi, J, Hill, A, Farrell, T, Davis, NF, Kearney, D, Nelson, T, Picciariello, A, Papagni, V, Altomare, DF, Granieri, S, Cotsoglou, C, Cabeleira, A, Branco, C, Serralheiro, P, Alves, R, Teles, T, Lazaro, A, Canhoto, C, Simoes, J, Costa, M, Almeida, AC, Nogueira, O, Oliveira, A, Athayde Nemesio, R, Silva, M, Lopes, C, Amaral, MJ, Valente da Costa, A, Andrade, R, Martins, R, Guimaraes, A, Guerreiro, P, Ruivo, A, Camacho, C, Duque, M, Santos, E, Breda, D, Oliveira, JM, De Oliveira Lopez, AL, Garrido, S, Colino, M, De Barros, J, Correia, S, Rodrigues, M, Cardoso, P, Teixeira, J, Soares, AP, Morais, H, Pereira, R, Revez, T, Manso, MI, Domingues, JC, Henriques, P, Ribeiro, R, Ribeiro, VI, Cardoso, N, Sousa, S, Martins dos Santos, S, Miranda, P, Garrido, R, Peralta Ferreira, M, Ascensao, J, Costeira, B, Cunha, C, Rio Rodrigues, L, Sousa Fernandes, M, Azevedo, P, Ribeiro, J, Lourenco, I, Gomes, H, Mendinhos, G, Nobre Pinto, A, Martins dos Santos, G, Taflin, H, Abdou, H, Diaz, J, Richmond, M, Clark, J, O'Meara, L, Hanna, N, Cooper, Z, Salim, A, Hirji, SA, Brown, A, Chung, C, Hansen, L, Okafor, BU, Roxo, V, Raut, CP, Jolissaint, JS, Mahvi, DA, Reinke, C, Ross, S, Thompson, K, Manning, D, Perkins, R, Volpe, A, Merola, S, Ssentongo, A, Ssentongo, P, Oh, JS, Hazelton, J, Maines, J, Gusani, N, Garner, M, Horvath, S, Martin, RCG, Bhutiani, N, Choron, R, Peck, G, Soliman, F, Rehman, S, Abbas, A, Soliman, A, Kim, B, Jones, C, Dauer, MDE, Renza-Stingone, E, Hernandez, E, Gokcen, E, Kropf, E, Sufrin, H, Hirsch, H, Ross, H, Engel, J, Sewards, J, Poggio, J, Sanserino, K, Rae, L, Philp, M, Metro, M, McNelis, P, Petrov, R, Pazionis, T, Quintana, M, Jackson, H, Lumenta, DB, Nischwitz, SP, Richtig, E, Pau, M, Srekl-Filzmaier, P, Eibinger, N, Michelitsch, B, Fediuk, M, Papinutti, A, Seidel, G, Kahn, J, Cohnert, TU, Kantor, E, Kahiu, J, Hossain, N, Hosny, S, Sultana, A, Taggarsi, M, Vitone, L, Lambert, J, Vaz, OP, Sarantitis, I, Shrestha, D, Timbrell, S, Shugaba, A, Jones, GP, Gardner, A, Tripathi, SS, Greenhalgh, MS, Emerson, H, Vejsbjerg, K, McCormick, W, Fisher, A, Singisetti, K, Aawsaj, Y, Barry, C, Blanco, J, Vanker, R, Ghobrial, M, Jones, G, Kanthasamy, S, Fawi, H, Awadallah, M, Chen, F, Cheung, J, Tingle, S, Abbadessa, F, Sachdeva, A, Rai, B, Chan, CD, McPherson, I, Booth, K, Ali, Mahmoud F, Pandanaboyana, S, Grainger, T, Nandhra, S, Patience, A, Rogers, A, Roy, C, Williams, T, Dawe, N, McCaffer, C, Riches, J, Bhattacharya, S, Moir, J, Kalson, NS, Ahmed, Elamin H, Mellor, C, Saleh, C, Koshy, RM, Hammond, J, Sanderson, L, Wahed, S, Phillips, AW, Ghosh, K, Rogers, LJ, Labib, PL, Miller, D, Minto, G, Hope, N, Marchbank, A, Emslie, K, Panahi, P, Ho, B, Perkins, C, Clough, E, Roy, H, Enemosah, I, Campbell, R, Natale, J, Gohil, K, Rela, M, Raza, N, Menakaya, C, Webb, JI, Antar, M, Modi, N, Sofat, R, Noel, J, Nunn, R, Adegbola, S, Eriberto, F, Sharma, V, Tanna, R, Lodhia, S, Carvalho, L, Osorio, C, Antunes, J, Lourenco, S, Balau, P, Godinho, M, Pereira, A, Keller, Deborah S, Smart, Neil J, Collaborative, COVIDSurg, Khatri, C, Ward, AE, Nepogodiev, D, Ahmed, I, Chaudhry, D, Dhaif, F, Bankhad-Kendall, B, Kaafarani, H, Bretherton, C, Mahmood, A, Marais, L, Parsons, N, Bhangu, A, Metcalfe, A, Siaw-Acheampong, K, Dawson, BE, Evans, JP, Glasbey, JC, Gujjuri, RR, Heritage, E, Jones, CS, Kamarajah, SK, Keatley, JM, Lawday, S, Li, E, Mckay, SC, Pellino, G, Tiwari, A, Simoes, JFF, Trout, IM, Venn, ML, Wilkin, RJW, Ademuyiwa, AO, Agarwal, A, Al Ameer, E, Alderson, D, Alser, O, Arnaud, AP, Augestad, KM, Bankhead-Kendall, B, Benson, RA, Chakrabortee, S, Blanco-Colino, R, Brar, A, Bravo, AM, Breen, KA, Buarque, IL, Caruana, E, Cunha, MF, Davidson, GH, Desai, A, Di Saverio, S, Edwards, J, Elhadi, M, Farik, S, Fiore, M, Fitzgerald, JE, Ford, S, Gallo, G, Ghosh, D, Gomes, GMA, Griffiths, E, Halkias, C, Harrison, EM, Hutchinson, P, Isik, A, Kolias, A, Lawani, I, Lederhuber, H, Leventoglu, S, Loffler, MW, Martin, J, Mashbari, H, Mazingi, D, Mohan, H, Moore, R, Moszkowicz, D, Ng-Kamstra, JS, Metallidis, S, Moug, S, Niquen, M, Ntirenganya, F, Outani, O, Pata, F, Pinkney, TD, Pockney, P, Radenkovic, D, Ramos-De la Medina, A, Roberts, K, Santos, I, Schache, A, Schnitzbauer, A, Stewart, GD, Shaw, R, Shu, S, Soreide, K, Spinelli, A, Sundar, S, Tabiri, S, Townend, P, Tsoulfas, G, van Ramshorst, G, Vidya, R, Vimalachandran, D, Wright, N, Mak, JKC, Kulkarni, R, Sharma, N, Nankivell, P, Tirotta, F, Parente, A, Breik, O, Kisiel, A, Cato, LD, Saeed, S, Pathanki, AM, Almond, M, Kamal, M, Chebaro, A, Lecolle, K, Truant, S, El Amrani, M, Zerbib, P, Pruvot, FR, Mathieu, D, Surmei, E, Mattei, L, Marin, H, Dudek, J, Singhal, T, El-Hasani, S, Nehra, D, Walters, A, Cuschieri, J, Ho, M, Wade, RG, Johnstone, J, Bourke, G, Brunelli, A, Elkadi, H, Otify, M, Pompili, C, Burke, JR, Bagouri, E, Chowdhury, M, Abual-Rub, Z, Kaufmann, A, Munot, S, Lo, T, Young, A, Kowal, M, Wall, J, Peckham-Cooper, A, Winter, SC, Belcher, E, Stavroulias, D, Di Chiara, F, Wallwork, K, Qureishi, A, Lami, M, Sravanam, S, Mastoridis, S, Shah, K, Chidambaram, S, Smillie, R, Shaw, AV, Bandyopadhyay, S, Cernei, C, Jeyaretna, D, Ganau, M, Piper, RJ, Duck, E, Brown, S, Jelley, C, Tucker, SC, Bond-Smith, G, Griffin, XL, Tebala, GD, Neal, N, Vatish, M, Noton, TM, Ghattaura, H, Maher, M, Fu, H, Risk, OBF, Majd, HS, Sinha, S, Shankar, S, Aggarwal, A, Kharkar, H, Lakhoo, K, Verberne, C, Senent-Boza, A, Sanchez-Arteaga, A, Benitez-Linero, I, Manresa-Manresa, F, Tallon-Aguilar, L, Melero-Cortes, L, Fernandez-Marin, MR, Duran-Munoz-Cruzado, VM, Ramallo-Solis, I, Beltran-Miranda, P, Pareja-Ciuro, F, Anton-Eguia, BT, Dawson, AC, Drane, A, Mompean, FO, Gomez-Rosado, J, Reguera-Rosal, J, Valdes-Hernandez, J, Capitan-Morales, L, Lopez, MDD, Patel, M, Shabana, A, Alanbuki, A, Usman, O, Tang, A, Beamish, AJ, Price, C, Bosanquet, D, Magowan, D, Solari, F, Williams, G, Nassa, H, Smith, L, Elliott, L, Mccabe, G, Holroyd, D, Jamieson, NB, Mariani, NM, Nicastro, V, Li, Z, Parkins, K, Spencer, N, Harries, R, Egan, RJ, Motter, D, Jenvey, C, Mahoney, R, Fine, N, Minto, T, Henry, A, Gill, C, Dunne, N, Sarma, DR, Godbole, C, Carlos, W, Tewari, N, Jeevan, D, Naredla, P, Khajuria, A, Connolly, H, Robertson, S, Sweeney, C, Di Taranto, G, Shanbhag, S, Dickson, K, McEvoy, K, Skillman, J, Sait, M, Al-omishy, H, Baig, M, Heer, B, Lunevicius, R, Sheel, ARG, Sundhu, M, Santini, AJA, Fathelbab, MSAT, Hussein, KMA, Nunes, QM, Jones, RP, Shahzad, K, Haq, I, Baig, MMAS, Hughes, JL, Kattakayam, A, Rajput, K, Misra, N, Shah, SB, Clynch, AL, Georgopoulou, N, Sharples, HM, Apampa, AA, Nzenwa, IC, Sud, A, Podolsky, D, Coleman, NL, Callahan, M, Dunstan, M, Beak, P, Gerogiannis, I, Ebrahim, A, Alwadiya, A, Goyal, A, Phillips, A, Bhalla, A, Demetriou, C, Grimley, E, Theophilidou, E, Ogden, E, Malcolm, FL, Davies-Jones, G, Ng, JCK, Mirza, M, Hassan, M, Elmaleh, N, Daliya, P, Williams, S, Bateman, A, Chia, Z, A'Court, J, Konarski, A, Faulkner, G, Talwar, R, Patel, K, Askari, A, Jambulingam, PS, Shaw, S, Maity, A, Hatzantonis, C, Sagar, J, Kudchadkar, S, Cirocchi, N, Chan, CH, Eberbach, H, Bayer, J, Erdle, B, Sandkamp, R, Breen, K, Velmahos, G, Maurer, LR, El Moheb, M, Gaitanidis, A, Naar, L, Christensen, MA, Kapoen, C, Langeveld, K, El Hechi, M, Mokhtari, A, Main, B, Maccabe, T, Newton, C, Blencowe, NS, Fudulu, DP, Bhojwani, D, Baquedano, M, Caputo, M, Rapetto, F, Flannery, O, Hassan, A, Ward, A, Tadross, D, Majkowski, L, Blundell, C, Forlani, S, Nair, R, Guha, S, Brown, SR, Steele, C, Kelty, CJ, Newman, T, Lee, M, Chetty, G, Lye, G, Balasubramanian, SP, Shah, NS, Sherif, M, Al-mukhtar, A, Whitehall, E, Giblin, A, Wells, F, Sharkey, A, Adamec, A, Madan, S, Konsten, J, Van Heinsbergen, M, Sou, A, Simpson, D, Hamilton, E, Blair, J, Fraile, JJ, Morales-Garcia, D, Carrillo-Rivas, M, Martinez, ET, Pascual, A, Landaluce-Olavarria, A, De Miguel, MG, Cruzado, LFG, Begona, E, Lecumberri, D, Rey, AC, Hervella, GMP, Carregal, LD, Fernandez, MIR, Freijeiro, M, Vega, SE, Van den Eynde, J, Oosterlinck, W, Van den Eynde, R, Sermon, A, Boeckxstaens, A, Cordonnier, A, De Coster, J, Jaekers, J, Politis, C, Miserez, M, Eri, MG, Montesino, JDG, Frigole, JD, Munoz, DN, Lizzi, V, Vovola, F, Arminio, A, Cotoia, A, Sarni, AL, Bekheit, M, Kamera, BS, Elhusseini, M, Sharma, P, Ahmeidat, A, Gradinariu, G, Cymes, W, Hannah, A, Mignot, G, Shaikh, S, Agilinko, J, Sgro, A, Rashid, MM, Milne, K, McIntyre, J, Akhtar, MA, Turnbull, A, Brunt, A, Stewart, KE, Wilson, MSJ, Rutherford, D, McGivern, K, Massie, E, Duff, S, Moura, F, Brown, BC, Khan, A, Asaad, P, Wadham, B, Aneke, IA, Collis, J, Warburton, H, Thomas, M, Pearce, L, Fountain, DM, Laurente, R, Sigamoney, KV, Dasa, M, George, K, Naqui, Z, Galhoum, M, Lipede, C, Gabr, A, Radhakrishnan, A, Hasan, MT, Kalenderov, R, Pathmanaban, O, Colombo, F, Chelva, R, Subba, K, Abou-Foul, AK, Khalefa, M, Hossain, F, Moores, T, Pickering, L, Shah, J, Anthoney, J, Emmerson, O, Bevan, K, Makin-Taylor, R, Ong, CS, Callan, R, Bloom, O, Chauhan, G, Kaur, J, Burahee, A, Bleibleh, S, Pigadas, N, Snee, D, Bhasin, S, Crichton, A, Habeebullah, A, Bodla, AS, Yassin, N, Mondragon, M, Dewan, V, Giuffrida, MC, Marano, A, Palagi, S, Grimaldi, SD, Testa, V, Peluso, C, Borghi, F, Simonato, A, Puppo, A, D'Agruma, M, Chiarpenello, R, Pellegrino, L, Maione, F, Cianflocca, D, Pruiti, CV, Giraudo, G, Gelarda, E, Dalmasso, E, Abrate, A, Daniele, A, Ciriello, V, Rosato, F, Garnero, A, Leotta, L, Chiozza, M, Anania, G, Urbani, A, Radica, MK, Carcoforo, P, Portinari, M, Sibilla, M, Archer, JE, Odeh, A, Siddaiah, N, Baumber, R, Parry, J, Carmichael, H, Velopulos, CG, Wright, FL, Urban, S, McIntyre, RC, Schroeppel, TJ, Hennessy, EA, Dunn, J, Zier, L, Parmar, C, Mccluney, S, Shah, S, Vives, JMM, Osorio, A, Diaz, CJG, Guariglia, CA, Montesinos, CS, Sanchon, L, Martinez, MX, Guardia, N, Collera, P, Del Gobbo, RD, Jimenez, RS, Font, RF, Clotet, RF, Brathwaite, CEM, Liu, H, Petrone, P, Hakmi, H, Sohail, AH, Baltazar, G, Heckburn, R, Aujayeb, A, Townshend, D, McLarty, N, Shenfine, A, Jackson, K, Johnson, C, Madhvani, K, Hampton, M, Hormis, AP, Young, R, Miu, V, Sheridan, K, MacDonald, L, Green, S, Onos, L, Dean, B, Luney, C, Myatt, R, Williams, MA, McVeigh, J, Alqallaf, A, Ben-Sassi, A, Mohamed, I, Mellor, K, Joshi, P, Joshi, Y, Crichton, R, Sonksen, J, Aldridge, K, Layton, GR, Karki, B, Jeong, H, Pankhania, S, Asher, S, Folorunso, A, Mistry, S, Singh, B, Winyard, J, Mangwani, J, Babu, BHB, Liyanage, ASD, Newman, S, Blake, I, Weerasinghe, C, Ballabio, M, Bisagni, P, Longhi, M, Armao, T, Madonini, M, Gagliano, A, Pizzini, P, Alga, A, Nordberg, M, Sandblom, G, Jallad, S, Lord, J, Anderson, C, El Kafsi, J, Logishetty, K, Saadya, A, Midha, R, Ip, M, Ponniah, HS, Stockdale, T, Bacarese--Hamilton, T, Foster, L, James, A, Anjarwalla, N, Henriques, DM, Hettige, R, Baban, C, Tenovici, A, Salerno, G, Hardie, J, Page, S, Anazor, F, King, SD, Luck, J, Kazzaz, S, HKruijff, S, De Vries, JPPM, Steinkamp, PJ, Jonker, PKC, Van der Plas, WY, Bierman, W, Janssen, Y, Borgstein, ABJ, Gisbertz, SS, Henegouwen, MIV, Enjuto, D, Gonzalez, MP, Pena, PD, Gonzalez, J, De Salas, MM, Pascual, PM, Gomez, LR, Garcia, RG, Bonilla, AR, Herrera-Merino, N, Bernabe, PF, Ortega, C, Hernandez, I, Rubio, EGD, Cervera, I, Kashora, F, Siddique, MH, Singh, A, Barmpagianni, C, Basgaran, A, Basha, A, Okechukwu, V, Bartsch, A, Gallagher, P, Maqsood, A, Sahnan, K, Leo, CA, Lewis, SE, Ubhi, HK, Exley, R, Khan, U, Shah, P, Saxena, S, Zafar, N, Abdul-Jabar, H, Mongelli, F, Bernasconi, M, Di Giuseppe, M, Christoforidis, D, La Regina, D, Arigoni, M, Liew, I, Al-Sukaini, A, Mediratta, S, Saxena, D, Brown, O, Boal, M, Dean, H, Higgs, S, Stanger, S, Abdalaziz, H, Constable, J, Ishii, H, Preece, R, Dovell, G, Reddy, RG, Dehal, A, Shah, HB, Cross, GWV, Seyed-Safi, P, Smart, YW, Kuc, A, Al-Yaseen, M, Jayasankar, B, Balasubramaniam, D, Abdelsaid, K, Mundkur, N, Gallagher, B, Hine, T, Keeler, B, Soulsby, RE, Taylor, A, Davies, E, Ryska, O, Raymond, T, Rogers, S, Tong, A, Hawkin, P, Kinnaman, G, Meagher, A, Sharma, I, Holler, E, Dunning, J, Viswanath, Y, Freystaetter, K, Dixon, J, Hadfield, JN, Hilley, A, Egglestone, A, Smith, B, Arkani, S, Freedman, J, Youssef, M, Sreedharan, L, Baskaran, D, Shaikh, I, Seebah, K, Reid, J, Watts, D, Kouritas, V, Chrastek, D, Maryan, G, Gill, DF, Khatun, F, Ranjit, S, Parakh, J, Sarodaya, V, Daadipour, A, Khalifa, M, Bosch, KD, Bashkirova, V, Dvorkin, LS, Kalidindi, VK, Choudhry, A, Marx, W, Segura-Illa, ME, Aniceto, GS, Castano-Leon, AM, Jimenez-Roldan, L, Fernandez, JD, Nunez, AP, Lagares, A, Perez, DG, Santas, M, Paredes, I, Sinovas, OE, Moreno-Gomez, L, Rubio, E, Vega, V, Lopez, AV, Martinez, ML, Villar, OG, Torres, PMP, Garcia-Borda, J, Herrero, EF, Gomez, P, Fernandez, CE, Ojeda-Thies, C, Garcia, JMP, Jones, HW, Divecha, H, Whelton, C, Board, T, Hardie, C, Powell-Smith, E, Alotaibi, M, Maashi, A, Zowgar, A, Alsakkaf, M, Izquierdo, O, Ventura, D, Castellanos, J, Lara, A, Escobar, D, Arrieta, M, de Cortazar, UG, Garcia, IV, Cioci, A, Ruiz, G, Allen, M, Rakoczy, K, Pavlis, W, Saberi, R, Sobti, A, Khaleel, A, Unnithan, A, Memon, K, Bhaskar, RRP, Maqboul, F, Kamel, F, Al-Samaraee, A, Madani, R, Kumar, L, Nisar, P, Agrawal, S, Bayo, HL, Duchateau, N, De Gheldere, C, Cheng, D, Yang, H, Fayad, A, Wood, ML, Persad, A, Groot, G, Pham, H, Hakami, I, Boeker, C, Mall, J, Smith, H, Haugstvedt, AF, Jonsson, M, Vivancos, PC, Ateca, IV, Calvo, MP, Playa, PM, Gainza, A, Achig, EJA, Fraga, AR, Corcostegui, IM, Ormaechea, GM, Gutierrez, JJG, Barbier, L, Peralta, MAP, Jimenez, MJ, Martin, JAM, Suarez, JG, Opere, GG, Gomez, LAP, Aguirre, MO, Fernandez-Colorado, A, De la Rosa-Estadella, M, Gasulla-Rodriguez, A, Serrano-Martin, M, Peig-Font, A, Junca-Marti, S, Juarez-Pomes, M, Garrido-Ondono, S, Blasco-Torres, L, Molina-Corbacho, M, Maldonado-Sotoca, Y, Gasset-Teixidor, A, Blasco-Moreu, J, Turrado-Rodriguez, V, Lacy, AM, de Lacy, FB, Morales, X, Carreras-Castaner, A, Torner, P, Jornet-Gibert, M, Balaguer-Castro, M, Renau-Cerrillo, M, Camacho-Carrasco, P, Vives-Barquiel, M, Campuzano-Bitterling, B, Gracia, I, Pujol-Muncunill, R, Gomez, ME, Padilla-Valverde, D, Sanchez-Garcia, S, Sanchez-Pelaez, D, Higuera, EJ, Rodriguez, RP, Camunas, AF, Martinez-Pinedo, C, Santos, EPG, Munoz-Atienza, V, Perez, AM, Cano, CALD, Crego-Vita, D, Huecas-Martinez, M, Domenech, J, Anon, AR, Sanguesa, MJ, Bernal-Sprekelsen, JC, Bauset, JCC, Ferrer, PR, Perez, CM, Gil-Albarova, O, Estelles, JG, Aghababyan, K, Rivas, R, Rivas, F, Escartin, J, Laina, JLB, Nogues, A, Cros, B, El-Abur, IT, Egea, JG, Yanez, C, Kauppila, JH, Sarjanoja, E, Tzedakis, S, Bouche, PA, Gaujoux, S, Gossot, D, Seguin-Givelet, A, Fuks, D, Grigoroiu, M, Salas, RS, Cathelineau, X, Macek, P, Barbe, Y, Rozet, F, Barret, E, Mombet, A, Cathala, N, Brian, E, Zadegan, F, Conso, C, Baldwin, AJ, West, R, Gammeri, E, Catton, A, Kouris, SM, Pereca, J, Singh, J, Patel, P, Handa, S, Kaushal, M, Kler, A, Reghuram, V, Tezas, S, Oktseloglou, V, Mosley, F, Monroy, MFID, Bobak, P, Omar, I, Ahad, S, Langlands, F, Brown, V, Hashem, M, Williams, A, Ridgway, A, Pournaras, D, Britton, E, Lostis, E, Ambler, GK, Chu, H, Hopkins, J, Manara, J, Chan, M, Doe, M, Moon, RDC, Jichi, T, Singleton, W, Mannion, R, Ramzi, J, Mohan, M, Singh, AA, Ashcroft, J, Baker, OJ, Coughlin, P, Davies, RJ, Durst, AZED, Abood, A, Habeeb, A, Hudson, VE, Lamb, B, Luke, L, Mitrasinovic, S, Murphy, S, Ngu, AWT, O'Neill, JR, Waseem, S, Wong, K, Georgiades, F, Hutchinson, PJ, Tan, XS, Pushpa-rajah, J, Colquhoun, A, Masterson, L, Abu-Nayla, I, Walker, C, Balakrishnan, A, Rooney, S, Irune, E, Byrne, MHV, Durrani, A, Richards, T, Venkatesan, AS, Combellack, T, Williams, J, Tahhan, G, Mohammed, M, Kornaszewska, M, Valtzoglou, V, Deglurkar, I, Rahman, M, Von Oppell, U, Mehta, D, Koutentakis, M, Chek, SAHSN, Hill, G, Morris, C, Shinkwin, M, Torkington, J, Cornish, J, Houston, R, Mannan, S, Ayeni, F, Tustin, H, Bordenave, M, Robson, A, Manu, N, Eardley, N, Krishnan, E, Serevina, OL, Martin, E, Smith, C, Jones, A, Mahapatra, SR, Clifford, R, Matthews, W, Mohankumar, K, Khawaja, I, Palepa, A, Doulias, T, Premakumar, Y, Jauhari, Y, Koshnow, Z, Bowen, D, Uberai, A, Hirri, F, Stubbs, BM, McDonald, C, Manickavasagam, J, Ragupathy, K, Davison, S, Dalgleish, S, McGrath, N, Kanitkar, R, Payne, CJ, Ramsay, L, Ng, CE, Collier, T, Khan, K, Evans, R, Brennan, C, Henshall, DE, Drake, T, Zamvar, V, Tambyraja, A, Skipworth, RJE, Linder, G, McGregor, R, Brennan, P, Mayes, J, Ross, L, Smith, S, White, T, Jamjoom, AAB, Pasricha, R, Holme, T, Abbott, S, Razik, A, Thrumurthy, S, Steinke, J, Baker, M, Howden, D, Baxter, Z, Osagie, L, Bence, M, Fowler, GE, Massey, L, Rajaretnam, N, Evans, J, John, J, Goubran, A, Campain, N, McDermott, FD, McGrath, JS, Ng, M, Pascoe, J, Phillips, JRA, Daniels, IR, Raptis, DA, Pollok, JM, Machairas, N, Davidson, B, Fusai, G, Soggiu, F, Xyda, S, Salinas, CH, Tzerbinis, H, Pissanou, T, Gilliland, J, Chowdhury, S, Varcada, M, Hart, C, Mirnezami, R, Knowles, J, Angamuthu, N, Vijay, V, Shakir, T, Hasan, R, Tansey, R, Ross, E, Loubani, M, Wilkins, A, Cao, H, Capitelli-McMahon, H, Hitchman, L, Ikram, H, Andronic, A, Ibrahim, AA, Totty, J, Tayeh, S, Chase, T, Humphreys, L, Ayorinde, J, Ghanbari, A, Cuming, T, Williams, K, Chung, E, Hagger, R, Karim, A, Hainsworth, A, Flatman, M, Trompeter, A, Hing, C, Tsinaslanidis, P, Benjamin, MW, Leyte, A, Tan, C, Smelt, J, Vaughan, P, Santhirakumaran, G, Hunt, I, Raza, M, Labib, A, Luo, X, Sudarsanam, A, Rolls, A, Lyons, O, Onida, S, Shalhoub, J, Sugand, K, Park, C, Sarraf, KM, Erridge, S, Kinross, J, Denning, M, Yalamanchili, S, Abuown, A, Ibrahim, M, Martin, G, Davenport, D, Wheatstone, S, Andreani, S, Bath, MF, Sahni, A, Judkins, N, Springford, LR, Sohrabi, C, Bacarese-Hamilton, J, Taylor, FG, Patki, P, Tanabalan, C, Reynolds, J, Alexander, ME, Smart, CJ, Stylianides, N, Abdalla, M, Newton, K, Bhatia, K, Edmondson, R, Abdeh, L, Jones, D, Zeiton, M, Ismail, O, Naseem, H, Advani, R, Fell, A, Smith, A, Nikolaou, S, English, C, Kristinsson, S, Oni, T, Ilahi, N, Ballantyne, K, Woodward, Z, Merh, R, Robertson-Smith, B, Mahmoud, A, Ameerally, P, Finch, JG, Gnanachandran, C, Pop, I, Rogers, M, Yousef, Y, Woods, R, Zahid, H, Mundy, G, Dass, D, Ford, D, Khan, J, Thiruchandran, G, Toh, SKC, Ahmad, Y, Allana, A, Bellis, C, Babawale, O, Phan, YC, Lokman, U, Ismail, M, Koc, T, Witek, A, Duggleby, L, Shamoon, S, Stefan, S, Clancy, H, Singh, S, Mukherjee, S, Ferguson, D, Mansuri, A, Thakrar, A, Wickramarachchi, L, Cuthbert, R, Sivayoganathan, S, Chui, K, Karam, E, Dott, C, Singh, R, Lane, J, Colvin, HV, Badran, A, Cadersa, A, Cumpstey, A, Hamady, Z, Aftab, R, Wensley, F, Byrne, J, Morrison-Jones, V, Sekhon, GK, Shields, H, Shakoor, Z, Yener, A, Talbot, T, Alzetani, A, Cresner, R, Johnson, D, Hughes, I, Hall, J, Rooney, J, Chatterji, S, Zhang, Y, Owen, R, Rudic, M, Hunt, J, Zakai, D, Aladeojebi, A, Ali, M, Gaunt, A, Barmayehvar, B, Kitchen, M, Gowda, M, Mansour, F, Jarvis, M, Halliday, E, Lefroy, R, Nanjaiah, P, Ali, S, Lin, DJ, Rajgor, AD, Scurrah, RJ, Kang, C, Watson, LJ, Harris, G, Royle, T, Cunningham, Y, James, G, Steel, B, Luk, ACO, Stables, G, Doorgakant, A, Thiruvasagam, VG, Carter, J, Reid, S, Mohammed, R, Marlow, W, Ferguson, H, Wilkin, R, Konstantinou, C, Yershov, D, Vatish, J, Denning, A, Das, R, Powell, S, Magee, C, Agarwal, K, Mangos, E, Nambirajan, T, Flindall, I, Mahendran, V, Hanson, A, De Marchi, J, Hill, A, Farrell, T, Davis, NF, Kearney, D, Nelson, T, Picciariello, A, Papagni, V, Altomare, DF, Granieri, S, Cotsoglou, C, Cabeleira, A, Branco, C, Serralheiro, P, Alves, R, Teles, T, Lazaro, A, Canhoto, C, Simoes, J, Costa, M, Almeida, AC, Nogueira, O, Oliveira, A, Nemesio, RA, Silva, M, Lopes, C, Amaral, MJ, da Costa, AV, Andrade, R, Martins, R, Guimaraes, A, Guerreiro, P, Ruivo, A, Camacho, C, Duque, M, Santos, E, Breda, D, Oliveira, JM, Lopez, ALD, Garrido, S, Colino, M, De Barros, J, Correia, S, Rodrigues, M, Cardoso, P, Teixeira, J, Soares, AP, Morais, H, Pereira, R, Revez, T, Manso, MI, Domingues, JC, Henriques, P, Ribeiro, R, Ribeiro, VI, Cardoso, N, Sousa, S, dos Santos, SM, Miranda, P, Garrido, R, Ferreira, MP, Ascensao, J, Costeira, B, Cunha, C, Rodrigues, LR, Fernandes, MS, Azevedo, P, Ribeiro, J, Lourenco, I, Gomes, H, Mendinhos, G, Pinto, AN, dos Santos, GM, Taflin, H, Abdou, H, Diaz, J, Richmond, M, Clark, J, O'Meara, L, Hanna, N, Cooper, Z, Salim, A, Hirji, SA, Brown, A, Chung, C, Hansen, L, Okafor, BU, Roxo, V, Raut, CP, Jolissaint, JS, Mahvi, DA, Reinke, C, Ross, S, Thompson, K, Manning, D, Perkins, R, Volpe, A, Merola, S, Ssentongo, A, Ssentongo, P, Oh, JS, Hazelton, J, Maines, J, Gusani, N, Garner, M, Horvath, S, Martin, RCG, Bhutiani, N, Choron, R, Peck, G, Soliman, F, Rehman, S, Abbas, A, Soliman, A, Kim, B, Jones, C, Dauer, MDE, Renza-Stingone, E, Hernandez, E, Gokcen, E, Kropf, E, Sufrin, H, Hirsch, H, Ross, H, Engel, J, Sewards, J, Poggio, J, Sanserino, K, Rae, L, Philp, M, Metro, M, McNelis, P, Petrov, R, Pazionis, T, Quintana, M, Jackson, H, Lumenta, DB, Nischwitz, SP, Richtig, E, Pau, M, Srekl-Filzmaier, P, Eibinger, N, Michelitsch, B, Fediuk, M, Papinutti, A, Seidel, G, Kahn, J, Cohnert, TU, Kantor, E, Kahiu, J, Hossain, N, Hosny, S, Sultana, A, Taggarsi, M, Vitone, L, Lambert, J, Vaz, OP, Sarantitis, I, Shrestha, D, Timbrell, S, Shugaba, A, Jones, GP, Gardner, A, Tripathi, SS, Greenhalgh, MS, Emerson, H, Vejsbjerg, K, McCormick, W, Fisher, A, Singisetti, K, Aawsaj, Y, Barry, C, Blanco, J, Vanker, R, Ghobrial, M, Jones, G, Kanthasamy, S, Fawi, H, Awadallah, M, Chen, F, Cheung, J, Tingle, S, Abbadessa, F, Sachdeva, A, Rai, B, Chan, CD, McPherson, I, Booth, K, Ali, FM, Pandanaboyana, S, Grainger, T, Nandhra, S, Patience, A, Rogers, A, Roy, C, Williams, T, Dawe, N, McCaffer, C, Riches, J, Bhattacharya, S, Moir, J, Kalson, NS, Ahmed, HE, Mellor, C, Saleh, C, Koshy, RM, Hammond, J, Sanderson, L, Wahed, S, Phillips, AW, Ghosh, K, Rogers, LJ, Labib, PL, Miller, D, Minto, G, Hope, N, Marchbank, A, Emslie, K, Panahi, P, Ho, B, Perkins, C, Clough, E, Roy, H, Enemosah, I, Campbell, R, Natale, J, Gohil, K, Rela, M, Raza, N, Menakaya, C, Webb, JI, Antar, M, Modi, N, Sofat, R, Noel, J, Nunn, R, Adegbola, S, Eriberto, F, Sharma, V, Tanna, R, Lodhia, S, Carvalho, L, Osorio, C, Antunes, J, Lourenco, S, Balau, P, Godinho, M, Pereira, A, Keller, DS, Smart, NJ, Apollo - University of Cambridge Repository, Collaborative, COVIDSurg, and Robotics and image-guided minimally-invasive surgery (ROBOTICS)
- Subjects
Male ,medicine.medical_specialty ,Multivariate analysis ,MORTALITY-RATES ,hip ,SURGERY ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,MULTICENTER ,COVIDSurg Collaborative ,1117 Public Health and Health Services ,Cohort Studies ,Medicine, General & Internal ,Internal medicine ,General & Internal Medicine ,medicine ,Dementia ,Humans ,Prospective Studies ,Aged, 80 and over ,COMPLICATIONS ,Science & Technology ,HIP-FRACTURES ,business.industry ,Hip Fractures ,SARS-CoV-2 ,COVID-19 ,1103 Clinical Sciences ,General Medicine ,Femoral fracture ,Perioperative ,medicine.disease ,Heart failure ,trauma management ,Medicine ,Surgery ,business ,Life Sciences & Biomedicine ,Femoral Fractures ,Kidney disease ,Cohort study ,1199 Other Medical and Health Sciences - Abstract
ObjectivesStudies have demonstrated high rates of mortality in people with proximal femoral fracture and SARS-CoV-2, but there is limited published data on the factors that influence mortality for clinicians to make informed treatment decisions. This study aims to report the 30-day mortality associated with perioperative infection of patients undergoing surgery for proximal femoral fractures and to examine the factors that influence mortality in a multivariate analysis.SettingProspective, international, multicentre, observational cohort study.ParticipantsPatients undergoing any operation for a proximal femoral fracture from 1 February to 30 April 2020 and with perioperative SARS-CoV-2 infection (either 7 days prior or 30-day postoperative).Primary outcome30-day mortality. Multivariate modelling was performed to identify factors associated with 30-day mortality.ResultsThis study reports included 1063 patients from 174 hospitals in 19 countries. Overall 30-day mortality was 29.4% (313/1063). In an adjusted model, 30-day mortality was associated with male gender (OR 2.29, 95% CI 1.68 to 3.13, p80 years (OR 1.60, 95% CI 1.1 to 2.31, p=0.013), preoperative diagnosis of dementia (OR 1.57, 95% CI 1.15 to 2.16, p=0.005), kidney disease (OR 1.73, 95% CI 1.18 to 2.55, p=0.005) and congestive heart failure (OR 1.62, 95% CI 1.06 to 2.48, p=0.025). Mortality at 30 days was lower in patients with a preoperative diagnosis of SARS-CoV-2 (OR 0.6, 95% CI 0.6 (0.42 to 0.85), p=0.004). There was no difference in mortality in patients with an increase to delay in surgery (p=0.220) or type of anaesthetic given (p=0.787).ConclusionsPatients undergoing surgery for a proximal femoral fracture with a perioperative infection of SARS-CoV-2 have a high rate of mortality. This study would support the need for providing these patients with individualised medical and anaesthetic care, including medical optimisation before theatre. Careful preoperative counselling is needed for those with a proximal femoral fracture and SARS-CoV-2, especially those in the highest risk groups.Trial registration numberNCT04323644
- Published
- 2021
5. Chest wall tuberculosis in children: a mimicker of bone tumour
- Author
-
Muthuvel Balasubramaniyan, Sanjay Verma, Akshay Kumar Saxena, and Sumeet R Dhawan
- Subjects
musculoskeletal diseases ,medicine.medical_specialty ,Sternum ,Tuberculosis ,030231 tropical medicine ,Antitubercular Agents ,Bone Neoplasms ,Case Report ,Tuberculosis, Osteoarticular ,03 medical and health sciences ,0302 clinical medicine ,Scapula ,Bone tumours ,030225 pediatrics ,medicine ,Humans ,Child ,Thoracic Wall ,Paediatric oncology ,business.industry ,Osteoarticular tuberculosis ,General Medicine ,medicine.disease ,Radiology ,Presentation (obstetrics) ,business - Abstract
Osteoarticular tuberculosis of flat bones of the chest wall such as sternum, scapula and rib is extremely rare in children. Because of its atypical clinical presentation mimicking malignant bone tumours, diagnosis remains a challenge. Histological and microbiological diagnosis remains confirmatory. Antitubercular therapy is the cornerstone in management.
- Published
- 2023
6. Arthrodesis in Acute and Chronic Lisfranc's Patients: A Retrospective Cohort Study
- Author
-
Amol Saxena, D. Scot Malay, Seth Ashraf, William Phillip Arthur, and Deepika Ratnala
- Subjects
Adult ,Tarsometatarsal joints ,medicine.medical_specialty ,medicine.medical_treatment ,Arthrodesis ,Nonunion ,Fracture Fixation, Internal ,Foot Joints ,medicine ,Humans ,Internal fixation ,Orthopedics and Sports Medicine ,Reduction (orthopedic surgery) ,Aged ,Retrospective Studies ,business.industry ,Biomechanics ,Retrospective cohort study ,Middle Aged ,medicine.disease ,Surgery ,Open Fracture Reduction ,medicine.anatomical_structure ,Concomitant ,business - Abstract
Injury to Lisfranc's joint complex affects the longitudinal and transverse arches of the foot and can significantly alter its biomechanics. Some of the previous studies have suggested primary arthrodesis to be superior to open reduction and internal fixation for treating primarily ligamentous Lisfranc injuries. Additionally, arthrodesis is often used for treating chronic Lisfranc injuries, including those which previously underwent open reduction and internal fixation and subsequently developed arthrosis. The purpose of this study was to retrospectively evaluate the outcomes of arthrodesis at the level of Lisfranc's articulation for both acute and chronic injuries. Patients who underwent midfoot arthrodesis surgical procedures between years 2001 and 2017 were retrospectively reviewed. About 187 patients with an average age of 55.9 ± 13.2 years old and a minimum follow-up of 1 year were included in the study. Median time to return to preoperative activities was 11 weeks. Overall successful joint fusion rate was 81.4%. However, concomitantly fused joints of the midfoot and hindfoot, in addition to the tarsometatarsal joints (TMTJ), were included in the overall fusion rate. Fusion rate at the first TMTJ was 90.2% (101 out of 112), second TMTJ was 94.4% (67 out of 71), and third TMTJ was 97.8% (45 out of 46). The present study demonstrates that patients who undergo arthrodesis for both acute and chronic Lisfranc injuries typically can return to activity in under approximately 3 months postoperatively (acute patients significantly faster) with a high union rate at the TMTJs. However, the overall union rate is significantly lower when concomitant proximal midfoot and rearfoot arthrodesis procedures are performed.
- Published
- 2022
7. Infectious complications in children with nephrotic syndrome: Can they be prevented?
- Author
-
Apoorv Saxena, Shobha Sharma, Suprita Kalra, Sumit Bhandari, and Hitesh Daryani
- Subjects
0301 basic medicine ,Pediatrics ,medicine.medical_specialty ,business.industry ,030106 microbiology ,Acute kidney injury ,Peritonitis ,General Medicine ,Urine ,Dipstick ,medicine.disease ,Anasarca ,03 medical and health sciences ,Pneumonia ,0302 clinical medicine ,Cellulitis ,medicine ,Original Article ,030212 general & internal medicine ,medicine.symptom ,business ,Nephrotic syndrome - Abstract
Background Sixty percent of children with nephrotic syndrome have frequently relapsing or steroid-dependent course. Serious infections like peritonitis, cellulitis, pneumonia etc. and anasarca with reduced urine output and complications there of including acute kidney injury and thromboembolism contribute significantly to morbidity and mortality in these children. Methods Questionnaire-based module to study infectious complications in children with nephrotic syndrome was circulated through survey monkey portal to paediatric nephrologists in our country. Twenty-two responded. Forty percent said that they saw patients with severe infections once a month. Fish bone analysis conducted on such patients reporting to our centre over next 3 months revealed that only 22% regularly monitored urine protein by dipstick. We proposed that reduction in time to report relapse by regularly monitoring urine protein could reduce complications in these children. Six urine protein dipsticks were handed over to patients who presented >7 days since relapse or with severe infection or anasarca in the last 1 year. These children were followed up for the next 1 year and given six more urine dipsticks every 3 months. Results Twenty-three patients were given urine protein dipsticks. Nine of them had 12 severe complications in the previous 6 months. None had any serious infections/anasarca on follow-up. Sixteen new patients had 14 serious complications in this time. Conclusions Early detection of relapse by home monitoring of urine protein by dipsticks was effective in significantly reducing the number of patients with severe infections and anasarca with reduced urine output.
- Published
- 2022
8. Fungi, host immune response, and tumorigenesis
- Author
-
Rohin Patel, Anjana Saxena, George Miller, Deepak Saxena, Miar Elaskandrany, and Mintoo Patel
- Subjects
0301 basic medicine ,Carcinogenesis ,Physiology ,medicine.medical_treatment ,Adenocarcinoma ,Biology ,medicine.disease_cause ,03 medical and health sciences ,0302 clinical medicine ,Immune system ,Physiology (medical) ,Pancreatic cancer ,medicine ,Animals ,Humans ,Human virome ,Microbiome ,Tumor microenvironment ,Hepatology ,Gastroenterology ,Cancer ,Immunotherapy ,Mini-Review ,medicine.disease ,Pancreatic Neoplasms ,030104 developmental biology ,030220 oncology & carcinogenesis ,Cancer research ,Mycobiome - Abstract
Advances in -omics analyses have tremendously enhanced our understanding of the role of the microbiome in human health and disease. Most research is focused on the bacteriome, but scientists have now realized the significance of the virome and microbial dysbiosis as well, particularly in noninfectious diseases such as cancer. In this review, we summarize the role of mycobiome in tumorigenesis, with a dismal prognosis, and attention to pancreatic ductal adenocarcinoma (PDAC). We also discuss bacterial and mycobial interactions to the host’s immune response that is prevalently responsible for resistance to cancer therapy, including immunotherapy. We reported that the Malassezia species associated with scalp and skin infections, colonize in human PDAC tumors and accelerate tumorigenesis via activating the C3 complement-mannose-binding lectin (MBL) pathway. PDAC tumors thrive in an immunosuppressive microenvironment with desmoplastic stroma and a dysbiotic microbiome. Host-microbiome interactions in the tumor milieu pose a significant threat in driving the indolent immune behavior of the tumor. Microbial intervention in multimodal cancer therapy is a promising novel approach to modify an immunotolerant (“cold”) tumor microenvironment to an immunocompetent (“hot”) milieu that is effective in eliminating tumorigenesis.
- Published
- 2021
9. Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest
- Author
-
Dankiewicz J., Cronberg T., Lilja G., Jakobsen J. C., Levin H., Ullen S., Rylander C., Wise M. P., Oddo M., Cariou A., Belohlavek J., Hovdenes J., Saxena M., Kirkegaard H., Young P. J., Pelosi P., Storm C., Taccone F. S., Joannidis M., Callaway C., Eastwood G. M., Morgan M. P. G., Nordberg P., Erlinge D., Nichol A. D., Chew M. S., Hollenberg J., Thomas M., Bewley J., Sweet K., Grejs A. M., Christensen S., Haenggi M., Levis A., Lundin A., During J., Schmidbauer S., Keeble T. R., Karamasis G. V., Schrag C., Faessler E., Smid O., Otahal M., Maggiorini M., Wendel Garcia P. D., Jaubert P., Cole J. M., Solar M., Borgquist O., Leithner C., Abed-Maillard S., Navarra L., Annborn M., Unden J., Brunetti I., Awad A., McGuigan P., Olsen R. B., Cassina T., Vignon P., Langeland H., Lange T., Friberg H., Nielsen N. Collaborators, Erik Roman Pognuz, Umberto Lucangelo, Giorgio Berlot, Elisabetta Macchini., Dankiewicz, J., Cronberg, T., Lilja, G., Jakobsen, J. C., Levin, H., Ullen, S., Rylander, C., Wise, M. P., Oddo, M., Cariou, A., Belohlavek, J., Hovdenes, J., Saxena, M., Kirkegaard, H., Young, P. J., Pelosi, P., Storm, C., Taccone, F. S., Joannidis, M., Callaway, C., Eastwood, G. M., Morgan, M. P. G., Nordberg, P., Erlinge, D., Nichol, A. D., Chew, M. S., Hollenberg, J., Thomas, M., Bewley, J., Sweet, K., Grejs, A. M., Christensen, S., Haenggi, M., Levis, A., Lundin, A., During, J., Schmidbauer, S., Keeble, T. R., Karamasis, G. V., Schrag, C., Faessler, E., Smid, O., Otahal, M., Maggiorini, M., Wendel Garcia, P. D., Jaubert, P., Cole, J. M., Solar, M., Borgquist, O., Leithner, C., Abed-Maillard, S., Navarra, L., Annborn, M., Unden, J., Brunetti, I., Awad, A., Mcguigan, P., Olsen, R. B., Cassina, T., Vignon, P., Langeland, H., Lange, T., Friberg, H., Collaborators:, Nielsen N., ROMAN-POGNUZ, Erik, Lucangelo, Umberto, Berlot, Giorgio, and Macchini, Elisabetta
- Subjects
Male ,Fever ,Heart disease ,medicine.medical_treatment ,Coma/etiology ,Hypothermia ,Kaplan-Meier Estimate ,Targeted temperature management ,GUIDELINES ,Out of hospital cardiac arrest ,Body Temperature ,law.invention ,TARGETED TEMPERATURE MANAGEMENT ,Randomized controlled trial ,Hypothermia, Induced ,law ,AMERICAN-HEART-ASSOCIATION ,EUROPEAN RESUSCITATION COUNCIL ,medicine ,Humans ,Single-Blind Method ,Cardiopulmonary resuscitation ,Coma ,610 Medicine & health ,Aged ,Cardiopulmonary Resuscitation ,Female ,Middle Aged ,Out-of-Hospital Cardiac Arrest ,Treatment Outcome ,business.industry ,Induced ,General Medicine ,medicine.disease ,Out-of-Hospital Cardiac Arrest/complications ,Fever/etiology ,Clinical research ,Hypothermia, Induced/adverse effects ,CARDIOPULMONARY-RESUSCITATION ,Anesthesia ,Cardiopulmonary Resuscitation/methods ,medicine.symptom ,business ,Human - Abstract
Hypothermia or Normothermia after Cardiac ArrestThis trial randomly assigned patients with coma after out-of-hospital cardiac arrest to undergo targeted hypothermia at 33 degrees C or normothermia with treatment of fever. At 6 months, there were no significant between-group differences regarding death or functional outcomes.BackgroundTargeted temperature management is recommended for patients after cardiac arrest, but the supporting evidence is of low certainty.MethodsIn an open-label trial with blinded assessment of outcomes, we randomly assigned 1900 adults with coma who had had an out-of-hospital cardiac arrest of presumed cardiac or unknown cause to undergo targeted hypothermia at 33 degrees C, followed by controlled rewarming, or targeted normothermia with early treatment of fever (body temperature, >= 37.8 degrees C). The primary outcome was death from any cause at 6 months. Secondary outcomes included functional outcome at 6 months as assessed with the modified Rankin scale. Prespecified subgroups were defined according to sex, age, initial cardiac rhythm, time to return of spontaneous circulation, and presence or absence of shock on admission. Prespecified adverse events were pneumonia, sepsis, bleeding, arrhythmia resulting in hemodynamic compromise, and skin complications related to the temperature management device.ResultsA total of 1850 patients were evaluated for the primary outcome. At 6 months, 465 of 925 patients (50%) in the hypothermia group had died, as compared with 446 of 925 (48%) in the normothermia group (relative risk with hypothermia, 1.04; 95% confidence interval [CI], 0.94 to 1.14; P=0.37). Of the 1747 patients in whom the functional outcome was assessed, 488 of 881 (55%) in the hypothermia group had moderately severe disability or worse (modified Rankin scale score >= 4), as compared with 479 of 866 (55%) in the normothermia group (relative risk with hypothermia, 1.00; 95% CI, 0.92 to 1.09). Outcomes were consistent in the prespecified subgroups. Arrhythmia resulting in hemodynamic compromise was more common in the hypothermia group than in the normothermia group (24% vs. 17%, PConclusionsIn patients with coma after out-of-hospital cardiac arrest, targeted hypothermia did not lead to a lower incidence of death by 6 months than targeted normothermia. (Funded by the Swedish Research Council and others; TTM2 ClinicalTrials.gov number, .)
- Published
- 2021
10. Implantable Loop Recorder Monitoring and the Incidence of Previously Unrecognized Atrial Fibrillation in Patients on Hemodialysis
- Author
-
Bruce A. Koplan, Wolfgang C. Winkelmayer, Alexandru I. Costea, Prabir Roy-Chaudhury, James A. Tumlin, Vijay Kher, Don E. Williamson, Saurabh Pokhariyal, David M. Charytan, Don Williamson, James Tumlin, Vikranth Reddy, Kowdle Chandrasekhar Prakash, David Charytan, Suresh Chandra Tiwari, Amber Podoll, Sanjeev Jasuja, G. Leslie Walters, Kraig Wangsnes, Alexandru Costea, Selcuk Tombul, Balbir Singh, Brajesh Mishra, Sachin Yalagudri, Abhijeet Shelke, Calambur Narasimhan, A.M. Karthigesan, Abraham Oomman, K P Pramod Kumar, Bruce Koplan, Upendra Kaul, Tapan Ghose, Ripen Gupta, Arvind Sethi, Nikhil Kumar, Ramesh Hariharan, Rajnish Sardana, Arif Wahab, N.N. Khanna, Mark Smith, Suresh Kamath, Claude Galphin, Puneet Sodhi, Rajsekara Chakravarthy, Subba Rao Budithi, Finnian McCausland, Sanjeev Gulati, Munawer Dijoo, Upendra Singh, Salil Jain, Vishal Saxena, Gaurav Sagar, Rachel Fissell, Robert Foley, Charles A. Herzog, Peter A. McCullough, John D. Rogers, Peter Zimetbaum, Manish Assar, and Mark Kremers
- Subjects
medicine.medical_specialty ,hemodialysis ,implantable loop recorder ,business.industry ,Incidence (epidemiology) ,medicine.medical_treatment ,end stage kidney diseae (ESKD) ,Atrial fibrillation ,medicine.disease ,Diseases of the genitourinary system. Urology ,kidney failure ,Nephrology ,Internal medicine ,Cardiology ,medicine ,Implantable loop recorder ,atrial fibrillation ,In patient ,RC870-923 ,Hemodialysis ,business ,arrhythmias ,Stroke ,Dialysis - Abstract
Introduction: Atrial fibrillation (AF) is common in patients with kidney failure on hemodialysis (KF-HD). We determined both AF incidence and burden in patients with KF-HD using implantable loop recorder (ILR) monitoring. Methods: Patients with KF-HD were enrolled and received an ILR. In 6 monitoring months, the incidence of AF events lasting ≥6 minutes was captured. Demographic, clinical, and dialysis characteristics were collected, and associations with incident AF were estimated using negative binomial regression models and expressed as incidence rate ratios and 95% CIs. Results: We enrolled 66 patients with KF-HD (mean age = 56 years, 70% male); 59 (90%) were without previously diagnosed AF. AF lasting ≥6 minutes was detected in 18 of 59 subjects (31%) without previously diagnosed AF and in 5 of 7 subjects (71%) with a previous AF diagnosis. Among the 23 with detected AF, episodes were present on 16% of patient days. Although 14 of 23 patients (61%) had AF on 2.5 vs. 2.5 mEq/l: incidence rate ratio = 0.62; 95% CI, 0.48–0.80) was associated with lower AF risk whereas higher dialysate bicarbonate concentrations (>35 vs. 35 mEq/l: incidence rate ratio = 3.18; 95% CI, 1.13–8.94) were associated with higher AF risk. Conclusion: New AF was detected in approximately one-third of patients with KF-HD. AF affects a substantial proportion of patient days and may be an underappreciated cause of stroke in KF-HD.
- Published
- 2022
11. Trastuzumab Deruxtecan in HER2-Mutant Non–Small-Cell Lung Cancer
- Author
-
Julien Mazieres, Patrik Vitazka, Lyudmila Bazhenova, Pasi A. Jänne, Misako Nagasaka, DESTINY-Lung Trial Investigators, Enriqueta Felip, Luis Paz-Ares, Ryota Shiga, Yingkai Cheng, Yasushi Goto, Kapil Saxena, Kazuhiko Nakagawa, Maurice Pérol, Javad Shahidi, Jose M. Pacheco, Bob T. Li, David Planchard, Hibiki Udagawa, Egbert F. Smit, Suddhasatta Acharyya, Andreas Saltos, and CCA - Cancer Treatment and quality of life
- Subjects
Lung Diseases ,Male ,Oncology ,Immunoconjugates ,Lung Neoplasms ,Receptor, ErbB-2 ,Phases of clinical research ,Medical and Health Sciences ,ErbB-2 ,Trastuzumab ,Carcinoma, Non-Small-Cell Lung ,80 and over ,Non-Small-Cell Lung ,Lung ,Cancer ,Aged, 80 and over ,Standard treatment ,Lung Cancer ,Interstitial lung disease ,General Medicine ,Middle Aged ,Progression-Free Survival ,5.1 Pharmaceuticals ,6.1 Pharmaceuticals ,Female ,Development of treatments and therapeutic interventions ,Receptor ,medicine.drug ,Adult ,medicine.medical_specialty ,Clinical Trials and Supportive Activities ,Neutropenia ,Article ,Clinical Research ,DESTINY-Lung01 Trial Investigators ,General & Internal Medicine ,Internal medicine ,medicine ,Humans ,Lung cancer ,Adverse effect ,Aged ,business.industry ,Carcinoma ,Evaluation of treatments and therapeutic interventions ,Pneumonia ,medicine.disease ,Confidence interval ,Camptothecin ,Interstitial ,Lung Diseases, Interstitial ,business ,Follow-Up Studies - Abstract
Background Human epidermal growth factor receptor 2 (HER2)-targeted therapies have not been approved for patients with non-small-cell lung cancer (NSCLC). The efficacy and safety of trastuzumab deruxtecan (formerly DS-8201), a HER2 antibody-drug conjugate, in patients with HER2-mutant NSCLC have not been investigated extensively. Methods We conducted a multicenter, international, phase 2 study in which trastuzumab deruxtecan (6.4 mg per kilogram of body weight) was administered to patients who had metastatic HER2-mutant NSCLC that was refractory to standard treatment. The primary outcome was objective response as assessed by independent central review. Secondary outcomes included the duration of response, progression-free survival, overall survival, and safety. Biomarkers of HER2 alterations were assessed. Results A total of 91 patients were enrolled. The median duration of follow-up was 13.1 months (range, 0.7 to 29.1). Centrally confirmed objective response occurred in 55% of the patients (95% confidence interval [CI], 44 to 65). The median duration of response was 9.3 months (95% CI, 5.7 to 14.7). Median progression-free survival was 8.2 months (95% CI, 6.0 to 11.9), and median overall survival was 17.8 months (95% CI, 13.8 to 22.1). The safety profile was generally consistent with those from previous studies; grade 3 or higher drug-related adverse events occurred in 46% of patients, the most common event being neutropenia (in 19%). Adjudicated drug-related interstitial lung disease occurred in 26% of patients and resulted in death in 2 patients. Responses were observed across different HER2 mutation subtypes, as well as in patients with no detectable HER2 expression or HER2 amplification. Conclusions Trastuzumab deruxtecan showed durable anticancer activity in patients with previously treated HER2-mutant NSCLC. The safety profile included interstitial lung disease that was fatal in two cases. Observed toxic effects were generally consistent with those in previously reported studies. (Funded by Daiichi Sankyo and AstraZeneca; DESTINY-Lung01 ClinicalTrials.gov number, NCT03505710.).
- Published
- 2022
12. Genetic risk for obesity and the effectiveness of the ChooseWell 365 workplace intervention to prevent weight gain and improve dietary choices
- Author
-
Kaitlyn Alimenti, Douglas E. Levy, Marie-France Hivert, Richa Saxena, Anne N. Thorndike, Hassan S. Dashti, and Jessica L. McCurley
- Subjects
Adult ,Male ,medicine.medical_specialty ,Medicine (miscellaneous) ,Health Promotion ,Weight Gain ,Body Mass Index ,law.invention ,Food Preferences ,Randomized controlled trial ,Behavior Therapy ,Risk Factors ,law ,Intervention (counseling) ,Internal medicine ,Food choice ,Genetic predisposition ,Humans ,Medicine ,Nutritional Physiological Phenomena ,Obesity ,Genetic risk ,Nutrition and Dietetics ,business.industry ,Consumer Behavior ,Middle Aged ,medicine.disease ,Occupational Diseases ,Personnel, Hospital ,Original Research Communications ,Quartile ,Female ,Diet, Healthy ,medicine.symptom ,business ,Weight gain - Abstract
BACKGROUND: It is unknown whether behavioral interventions to improve diet are effective in people with a genetic predisposition to obesity. OBJECTIVES: To examine associations between BMI genetic risk and changes in weight and workplace purchases by employees participating in a randomized controlled trial of an automated behavioral workplace intervention to promote healthy food choices. METHODS: Participants were hospital employees enrolled in a 12-mo intervention followed by a 12-mo follow-up. Hospital cafeterias utilized a traffic-light labeling system (e.g., green = healthy, red = unhealthy) that was used to calculate a validated Healthy Purchasing Score (HPS; higher = healthier). A weighted genome-wide BMI genetic score was generated by summing BMI-increasing alleles. RESULTS: The study included 397 adults of European ancestry (mean age, 44.9 y; 80.9% female). Participants in the highest genetic quartile (Q4) had a lower HPS and higher purchases of red-labeled items relative to participants in the lowest quartile (Q1) at baseline [Q4–Q1 Beta HPS, –4.66 (95% CI, –8.01 to –1.32); red-labeled items, 4.26% (95% CI, 1.45%–7.07%)] and at the 12-mo [HPS, –3.96 (95% CI, –7.5 to –0.41); red-labeled items, 3.20% (95% CI, 0.31%–6.09%)] and 24-mo [HPS, –3.70 (95% CI, –7.40 to 0.00); red-labeled items, 3.48% (95% CI, 0.54%–6.41%)] follow-up periods. In the intervention group, increases in HPS were similar in Q4 and Q1 at 12 mo (Q4–Q1 Beta, 1.04; 95% CI, –2.42 to 4.50). At the 24-mo follow-up, the change in BMI from baseline was similar between Q4 and Q1 (0.17 kg/m(2); 95% CI, –0.55 to 0.89 kg/m(2)) in the intervention group, but higher in Q4 than Q1 (1.20 kg/m(2); 95% CI, 0.26–2.13 kg/m(2)) in the control group. No interaction was evident between the treatment arm and genetic score for BMI or HPS. CONCLUSIONS: Having a high BMI genetic risk was associated with greater increases in BMI and lower quality purchases over 2 y. The 12-mo behavioral intervention improved employees’ food choices, regardless of the genetic burden, and may have attenuated weight gain conferred by having the genetic risk.
- Published
- 2022
13. Systematic review of the effectiveness of homoeopathy in the treatment of autism spectrum disorder
- Author
-
Vibha Saxena, Udit Saxena, and Gish Chacko
- Subjects
Speech and Hearing ,medicine.medical_specialty ,Environmental Engineering ,Autism spectrum disorder ,business.industry ,Cognitive Neuroscience ,Public Health, Environmental and Occupational Health ,medicine ,Homeopathy ,medicine.disease ,Psychiatry ,business ,Sensory Systems - Published
- 2021
14. Thromboembolic and bleeding risks in edoxaban patients with pacemaker and cardiac monitoring procedures: Outcomes of the Global EMIT program
- Author
-
Thomas Vanassche, Paolo Colonna, Martin Unverdorben, Cathy Chen, Manish Saxena, Amparao Santamaria, James Jin, R G Wilkins, and Christian von Heymann
- Subjects
Male ,Pacemaker, Artificial ,medicine.medical_specialty ,Pyridines ,medicine.medical_treatment ,Population ,Taiwan ,Hemorrhage ,chemistry.chemical_compound ,Ischemia ,Risk Factors ,Edoxaban ,Thromboembolism ,Republic of Korea ,Humans ,Medicine ,Cardiac Resynchronization Therapy Devices ,Prospective Studies ,education ,Aged ,education.field_of_study ,business.industry ,Incidence (epidemiology) ,Anticoagulants ,Atrial fibrillation ,General Medicine ,Perioperative ,medicine.disease ,Thrombosis ,Europe ,Thiazoles ,chemistry ,Emergency medicine ,Female ,Cardiac monitoring ,Cardiology and Cardiovascular Medicine ,business ,Complication ,Factor Xa Inhibitors - Abstract
Introduction Limited data were published on the management of direct oral anticoagulants in the insertion of pacemaker and cardiac monitoring devices. This study describes the management and outcomes of edoxaban, a direct oral factor Xa inhibitor, in patients undergoing pacemaker or monitoring device implantation in routine clinical practice. Methods and results EMIT-AF/VTE collected data of patients from Europe, Korea, and Taiwan. Timing and duration of peri-procedural interruption of edoxaban were at the treating physician's discretion. Pacemakers or monitoring devices were implanted into 136 patients who were evaluated from five days pre- until 30 days post-procedure. The primary outcomes were the incidences of acute thromboembolic events (ATE), ischemic events, and International Society on Thrombosis and Haemostasis defined Major Bleeding; secondary outcomes included incidence of Clinically Relevant Non-Major Bleeding (CRNMB) and perioperative edoxaban interruption times. Conformance with European Heart Rhythm Association (EHRA) Guidance on interruption of DOAC therapy was variable: of the cardiac monitoring device patients, where no interruption of therapy would be expected, nonetheless, 62.5% had interruption of treatment, whereas in pacemaker procedures, where interruption would be expected, 23.4% had no interruption. No ATE or ischemic events occurred. One case of CRNMB and two of minor bleeding occurred. All bleedings occurred more than three days after the procedure. Conclusion/relevance The periprocedural complication risk for edoxaban treated patients undergoing pacemaker or invasive cardiac monitoring implantation was low. This population of patients was well managed in routine practice. This article is protected by copyright. All rights reserved.
- Published
- 2021
15. Phase <scp>III</scp> / <scp>IV</scp> , Randomized, <scp>Fifty‐Two</scp> –Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus Erythematosus
- Author
-
David M. Roth, Susan W Burriss, Michelle Miller, J. Groark, Kathleen Maksimowicz-McKinnon, Luiz Sergio Guedes Barbosa, Amy Pierce, Ellen M. Ginzler, Mittermayer Barreto Santiago, Beulah Ji, Jennifer A Gilbride, Saira Z Sheikh, Richard Furie, Amit Saxena, Jim C. Oates, Damon Bass, and David D'Cruz
- Subjects
education.field_of_study ,medicine.medical_specialty ,Systemic lupus erythematosus ,business.industry ,Immunology ,Population ,medicine.disease ,Placebo ,Belimumab ,Clinical trial ,Rheumatology ,Prednisone ,Internal medicine ,Clinical endpoint ,Immunology and Allergy ,Medicine ,business ,education ,Adverse effect ,medicine.drug - Abstract
Objective Enrollment of patients of Black African ancestry with systemic lupus erythematosus (SLE) in Phase 2 and 3 belimumab trials was not reflective of the racial distribution observed in the lupus population. This study assessed efficacy and safety of intravenous (IV) belimumab plus standard therapy in patients of self-identified black race. Methods EMBRACE (GSK Study BEL115471; NCT01632241): 52-week multicenter, double-blind (DB), placebo-controlled trial in adults of self-identified black race with active SLE, receiving monthly belimumab 10 mg/kg IV, or placebo, plus standard therapy. The optional 26-week open-label extension phase included patients who completed the DB phase. The primary endpoint was SLE Responder Index response rate at Week 52 with modified proteinuria scoring adapted from the SLEDAI-2K (SRI-S2K). Key secondary endpoints included: Week 52 SRI response rate, time to first severe flare, and reductions in prednisone dose. Results The modified intention-to-treat population comprised 448 patients (96.9% female; mean [standard deviation] age: 38.8 [11.42] years). The primary endpoint (SRI-S2K response rate at Week 52) was not achieved (belimumab 48.7%, placebo 41.6%; p=0.1068); however, numerical improvements favoring belimumab were observed, especially in patients with high baseline disease activity or renal manifestations. The safety profile of belimumab was generally consistent with previous SLE trials. Adverse events were the primary reason for DB phase withdrawals (belimumab 5.4%; placebo 6.7%). Conclusions The primary endpoint of this study was not achieved, but improvement with belimumab versus placebo was observed, suggesting that belimumab remains a suitable treatment option for SLE management in patients of Black African ancestry.
- Published
- 2021
16. Role of Shear Wave Elastography of Thyroid Gland in Children With Newly Diagnosed Hashimoto's Thyroiditis: Preliminary Study
- Author
-
Kushaljit Singh Sodhi, Divij Agarwal, Akshay Kumar Saxena, Devi Dayal, and Anmol Bhatia
- Subjects
Male ,medicine.medical_specialty ,Hashimoto Disease ,Gastroenterology ,Thyroiditis ,Thyroid-stimulating hormone ,Internal medicine ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Stage (cooking) ,Child ,Ultrasonography ,Triiodothyronine ,Radiological and Ultrasound Technology ,medicine.diagnostic_test ,business.industry ,Thyroid ,Ultrasound ,medicine.disease ,medicine.anatomical_structure ,Child, Preschool ,Elasticity Imaging Techniques ,Female ,Elastography ,business ,Hormone - Abstract
OBJECTIVES The data on the use of shear wave elastography (SWE) in children with thyroid disorders is limited. We aimed to assess the role of SWE in the evaluation of the thyroid gland in children newly diagnosed with Hashimoto's thyroiditis (HT). METHODS The thyroid gland was evaluated in 18 children (5 boys and 13 girls, age range: 5-12 years) with newly diagnosed HT and 27 (21 boys and 6 girls, age range: 4-12 years) healthy controls using grayscale ultrasound followed by SWE. The values of SWE (in kPa) were compared between cases and controls and were also correlated with various demographic variables and serum thyroid hormone concentrations. RESULTS The overall median of SWE values in cases and controls was 20.6 kPa (IQR = 19.16-26.94) and 10.7 kPa (IQR = 9.9-16.32), respectively, and the difference was statistically significant (W = 438.5, P
- Published
- 2021
17. Neutrophil extracellular traps and organ dysfunction in sepsis
- Author
-
Anupam Jyoti, Vijay Kumar Srivastava, Sanket Kaushik, Sanni Kumar, Juhi Saxena, and Nazrana Payal
- Subjects
Inflammation ,Innate immune system ,Neutrophils ,business.industry ,Multiple Organ Failure ,Biochemistry (medical) ,Clinical Biochemistry ,Organ dysfunction ,General Medicine ,Neutrophil extracellular traps ,medicine.disease ,Extracellular Traps ,Biochemistry ,Hypoxemia ,Pathogenesis ,Sepsis ,Immunology ,Coagulopathy ,Humans ,Medicine ,medicine.symptom ,business - Abstract
Sepsis is a clinical syndrome resulting from infection followed by inflammation and is one of the significant causes of mortality worldwide. The underlying reason is the host's uncontrolled inflammatory response due to an infection led to multiple organ dysfunction/failure. Neutrophils, an innate immune cell, are forerunners to reach the site of infection/inflammation for clearing the infection and resolute the inflammation during sepsis. A relatively new neutrophil effector function, neutrophil extracellular traps (NETs), have been demonstrated to kill the pathogens by releasing DNA decorated with histone and granular proteins. A growing number of pieces of shreds of evidence suggest that unregulated incidence of NETs have a significant influence on the pathogenesis of sepsis-induced multiple organ damage, including arterial hypotension, hypoxemia, coagulopathy, renal, neurological, and hepatic dysfunction. Thus, excessive production and improper resolution of NETs are of significant therapeutic value in combating sepsis-induced multiple organ failure. The purpose of this review is intended to highlight the role of NETs in sepsis-induced organ failure. Furthermore, the current status of therapeutic strategies to intersect the harmful effects of NETs to restore organ functions is discussed.
- Published
- 2021
18. Time spent in outdoor light is associated with mood, sleep, and circadian rhythm-related outcomes: A cross-sectional and longitudinal study in over 400,000 UK Biobank participants
- Author
-
Angus C. Burns, Céline Vetter, Andrew J. K. Phillips, Jacqueline M. Lane, Sean W. Cain, and Richa Saxena
- Subjects
Adult ,Male ,Longitudinal study ,Rate ratio ,Article ,Insomnia ,Humans ,Medicine ,Longitudinal Studies ,Aged ,Biological Specimen Banks ,Depressive Disorder, Major ,business.industry ,Chronotype ,Odds ratio ,Middle Aged ,medicine.disease ,Neuroticism ,United Kingdom ,Circadian Rhythm ,Psychiatry and Mental health ,Clinical Psychology ,Cross-Sectional Studies ,Mood ,Major depressive disorder ,Female ,medicine.symptom ,Sleep ,business ,Demography - Abstract
Background Light has powerful effects on mood, sleep, and the circadian system. Humans evolved in an environment with a clear distinction between day and night, but our modern environments have blurred this distinction. Negative effects of light exposure at night have been well characterized. The importance of daytime light exposure has been less well characterized. Here we examine the cross-sectional and longitudinal associations of time spent in daytime outdoor light with mood, sleep, and circadian-related outcomes. Methods Participants were drawn from the UK Biobank cohort, a large study of UK adults (n = 502,000; 37–73 years old; 54% women). Results UK Biobank participants reported spending a median of 2.5 daylight hours (IQR = 1.5–3.5 h) outdoors per day. Each additional hour spent outdoors during the day was associated with lower odds of lifetime major depressive disorder (95% CI OR:0.92–0.98), antidepressant usage (OR:0.92–0.98), less frequent anhedonia (OR:0.93–0.96) and low mood (OR:0.87–0.90), greater happiness (OR:1.41–1.48) and lower neuroticism (incident rate ratio, IRR:0.95–0.96), independent of demographic, lifestyle, and employment covariates. In addition, each hour of daytime light was associated with greater ease of getting up (OR:1.46–1.49), less frequent tiredness (OR:0.80–0.82), fewer insomnia symptoms (OR:0.94–0.97), and earlier chronotype (adjusted odds ratio; OR:0.75–0.77). Auto-Regressive Cross-Lagged (ARCL) models were used to examine the longitudinal association of time spent in outdoor light at baseline with later mood-, sleep- and circadian-related outcomes reported at time point 2. Overall, longitudinal associations support cross-sectional findings, though generally with smaller effect sizes. Limitations Future studies that examine the intensity of daytime light exposure at the ocular level are needed. Conclusions Our findings suggest that low daytime light exposure is an important environmental risk factor for mood, sleep, and circadian-related outcomes.
- Published
- 2021
19. Heart Failure in a Child
- Author
-
Jay Relan, Mansi Verma, Sanjeev Kumar, Madhavi Tripathi, Uma Devi Karuru, Anita Saxena, Sivasubramanian Ramakrishnan, Shyam Sundar Kothari, and Saurabh Gupta
- Subjects
medicine.medical_specialty ,MPA, main pulmonary artery ,pulmonary artery vasculitis ,RA, right atrium ,PPS, peripheral pulmonary artery stenosis ,Internal medicine ,LPA, left pulmonary artery ,Medicine ,Heart Failure ,ESR, erythrocyte sedimentation rate ,peripheral pulmonary artery stenosis ,business.industry ,FDG-PET, fluorodeoxyglucose-positron emission tomography ,medicine.disease ,RPA, right pulmonary artery ,TA, Takayasu arteritis ,pulmonary artery intervention ,RV, right ventricle ,PA, pulmonary artery ,congestive heart failure ,Heart failure ,Cardiology ,Case Report: Clinical Case ,Cardiology and Cardiovascular Medicine ,business ,Takayasu arteritis - Abstract
Heart failure secondary to isolated pulmonary artery vasculitis is rarely described in children. We describe a 10-year-old child who presented with right heart failure symptoms, severe pulmonary hypertension, and bilateral branch pulmonary artery stenosis secondary to isolated pulmonary artery vasculitis. (Level of Difficulty: Advanced.), Central Illustration
- Published
- 2021
20. Relationship between physical activity, objective sleep parameters, and circadian rhythm in patients with head and neck cancer receiving chemoradiotherapy: A longitudinal study
- Author
-
Rachita Gururaj, PU Prakash Saxena, Oxana Palesh, Stephen Rajan Samuel, Anupama Hegde, Ravishankar Nagaraja, and K Vijaya Kumar
- Subjects
Oncology ,circadian rhythm ,medicine.medical_specialty ,Longitudinal study ,RD1-811 ,Physical activity ,physical activity ,chemoradiotherapy ,Internal medicine ,Medicine ,In patient ,Circadian rhythm ,Original Research ,Sleep quality ,business.industry ,Head and neck cancer ,General Medicine ,sleep quality ,medicine.disease ,Sleep in non-human animals ,Sleep Medicine and Science ,Otorhinolaryngology ,RF1-547 ,head and neck cancer ,Surgery ,business ,Chemoradiotherapy - Abstract
Objectives This study was developed to assess the relationship between physical activity, sleep and circadian rhythm using accelerometer and urine melatonin levels in patients with head and neck cancer (HNC). Also, this study evaluated the changes in physical activity, sleep, and circadian rhythm during the seven‐week course of chemoradiotherapy. Methods This longitudinal study recruited 27 participants diagnosed with HNC who were planning to undergo chemoradiotherapy. Accelerometers worn for 3 days during the 1st, 3rd, and 7th weeks of chemoradiotherapy were used to assess physical activity levels (step count and metabolic equivalents [METs]) and sleep quality (total sleep time [TST], sleep onset latency [SOL], and sleep efficiency [SE]). Urine melatonin analysis was conducted using the morning void urine sample on 1st, 3rd, and 7th weeks. The change in variables during the seven weeks and the correlation between them were analyzed. Results During the seven weeks, trends of reduction in variables of physical activity, sleep and circadian rhythm were observed with significant decrease in step count, TST and melatonin levels. SE was found to have strong negative correlation with physical activity. TST was found to have moderate correlation with SE and step count. The variables of physical activity also showed moderate correlation among them. Conclusion This study concludes that higher physical activity is associated with poor SE due to increased night‐time activity. There was a significant reduction in physical activity and sleep observed during seven weeks with moderate association between them. The significant circadian rhythm deregulation however showed poor association with the other variables. Level of Evidence: 2b
- Published
- 2021
21. Psychiatric Patients with a Serious Mental Illness and a Recent History of Violent Behavior: An Exploration of Developmental, Clinical, Cognitive, and Demographic Characteristics
- Author
-
Feras Nadhim Hasoon Al Attar, Sheena Mathew, Qin-Lai Huang, Lida Wang, Shu-Guang Han, Hua Tang, Siyamol Chirakkarottu, Sisir Nandi, Said Afqir Khalid El Bairi, Mohit Kumar, Mridula Saxena, Anil Kumar Saxena, Tanos C. C. Franca, Mariam Amrani, Yi-Hau Chen, Pravin Shende, Hsiuying Wang, Xijie Yu, Steven M. Silverstein, Bala Prabhakar Pankaj Mandpe, José Daniel Figueroa-Villar, Elaine C. Petronilho, Kamil Kuca, and Xiuwen Wang, Xiang Chen, Lingyun Lu
- Subjects
03 medical and health sciences ,Psychiatry and Mental health ,medicine.medical_specialty ,0302 clinical medicine ,medicine ,Cognition ,030212 general & internal medicine ,Psychology ,Mental illness ,medicine.disease ,Psychiatry ,030227 psychiatry - Abstract
Background: Epidemiologic studies have shown that persons suffering from psychotic disorders are at increased risk of violent behavior. Several factors have been shown to predict violent behavior among persons with psychosis. However, prior research is limited in that these factors have not been explored simultaneously within the same study. Methods: The current study, therefore, aimed to determine which demographic, clinical, cognitive, and developmental characteristics were associated with an increased likelihood of violence among patients diagnosed with a psychotic disorder and which combination of these best predicted a history of violence. Participants (n=53) completed measures of demographics, violence risk, psychotic and personality symptoms, trauma, psychopathy and cognitive functioning. Results: Bivariate relationships were conducted to compare the history of violent behavior between all variables. Additionally, a binary logistic regression was run predicting participants’ history of violence. Several demographic, cognitive, clinical, and developmental factors were associated with increased odds of having a history of violence. The overall correct classification rate for the model was 92.2%, with 87.5% of participants without a history of violence and 91.4% with a history of violence being correctly classified. The model included antisocial personality traits, poor behavioral controls, head injury, not accepting responsibility, lacking goals, prior supervision failures, and HCR-20 total score. Conclusion: The binary logistic regression model showed good accuracy in predicting a history of violence in persons with psychosis. These findings are consistent with prior research and can inform efforts at risk assessment and identification of treatment targets for people with a psychotic disorder who are at highest risk of violence.
- Published
- 2020
22. Determinants of curative resection in incidental gallbladder carcinoma with special reference to timing of referral
- Author
-
Rajan Saxena, Rahul, Rajneesh Kumar Singh, Prabhakar Mishra, Ashish Kumar Singh, Neha Bhatt, and Kulbhushan Haldeniya
- Subjects
medicine.medical_specialty ,Multivariate analysis ,Referral ,business.industry ,medicine.medical_treatment ,Gallbladder ,Incidental gall bladder cancer ,Curative resection determinants ,medicine.disease ,Asymptomatic ,Metastasis ,Surgery ,Post-cholecystectomy interval ,medicine.anatomical_structure ,Laparotomy ,Carcinoma ,medicine ,Original Article ,General Materials Science ,Cholecystectomy ,medicine.symptom ,business - Abstract
Backgrounds/Aims Re-resection of incidental gallbladder carcinoma (IGBC) is possible in a select group of patients. However, the optimal timing for re-intervention lacks consensus. Methods A retrospective analysis was performed for a prospective database of 91 patients with IGBC managed from 2009 to 2018. Patients were divided into three groups based on the duration between the index cholecystectomy and re-operation or final staging: Early (E), < 4 weeks; Intermediate (I), > 4 weeks and < 12 weeks; and Late (L), > 12 weeks. Demographic data, tumor characteristics, and operative details of patients were analyzed to determine factors affecting the re-resectability of IGBC. Results Twenty-two patients in ‘E’, 48 in ‘I’, and 21 in ‘L’ groups were evenly matched. Nearly two thirds were asymptomatic. Curative resection was possible in 48 (52.7%) patients. Metastasis was detected during staging laparoscopy (SL)/laparotomy in 26 (28.6%) patients. The yield of SL was more in the ‘L’ group (30.8%) than in the ‘I’ (11.1%) or ‘E’ (nil) group, avoiding unnecessary laparotomy in 13.6%. Only 28.5% of patients in the ‘L’ group could undergo curative resection (R0/R1 resection), significantly less than that in the ‘E’ (50.0%) or ‘I’ group (64.6%) (both p < 0.001). On multivariate analysis, presentation in intermediate period and tumor differentiation increased the chance of curative resection (p < 0.05). Conclusions Asymptomatic patients in the ‘I’ group with well differentiated IGBC have the best chance of obtaining a curative resection.
- Published
- 2021
23. Extracorporeal life support and cardiopulmonary bypass for central airway surgery: A systematic review
- Author
-
Vakhtang Tchantchaleishvili, H. Todd Massey, Nathaniel R. Evans, Scott W. Cowan, Colin C Yost, Abhiraj Saxena, Rohinton J. Morris, Tyler R. Grenda, Thomas J. O’Malley, and Kyle W. Prochno
- Subjects
medicine.medical_specialty ,medicine.medical_treatment ,Respiratory System ,Biomedical Engineering ,Medicine (miscellaneous) ,Bioengineering ,Extracorporeal ,law.invention ,Biomaterials ,Extracorporeal Membrane Oxygenation ,law ,medicine ,Cardiopulmonary bypass ,Extracorporeal membrane oxygenation ,Humans ,Intubation ,Airway Management ,Cardiopulmonary Bypass ,business.industry ,General Medicine ,Perioperative ,medicine.disease ,Surgery ,Stenosis ,Life support ,Breathing ,business - Abstract
BACKGROUND Major airway surgery can pose a complex problem to perioperative central airway management. Adjuncts to advanced ventilation strategies have included cardiopulmonary bypass, veno-arterial, or veno-venous extracorporeal life support. We performed a systematic review to assess the existing evidence utilizing these strategies. METHODS An electronic search was conducted to identify studies written in English reporting the use of extracorporeal life support (ECLS) during central airway surgery. Thirty-six articles consisting of 78 patients were selected and patient-level data were analyzed. RESULTS Median patient age was 47 [IQR: 34-53] and 59.0% (46/78) were male. Indications for surgery included central airway or mediastinal cancer in 57.7% (45/78), lesion or injury in 15.4% (12/78), and stenosis in 12.8% (10/78). Support was initiated pre-operatively in 9.9% (7/71) and at the time of induction in 55.3% (42/76). It was most commonly used at the time of tracheal resection/repair [93.2% (68/73)], intubation of the tracheal stump [94.4% (68/72)], and re-anastomosis [94.2% (65/69)]; 13.7% (10/73) patients were supported post-operatively. The most commonly performed surgery was tracheal repair or resection in 70.3% (52/74). Median hospital stay was 12 [8, 25] days and in-hospital mortality was 7.9% (6/76). There was no significant difference in survival between the three groups (p = .54). CONCLUSIONS Extracorporeal membrane oxygenation offers versatility in timing, surgical approach, and ECLS runtime that makes it a viable addition to the surgical armamentarium for treating complex central airway pathologies.
- Published
- 2021
24. Superoxide dismutase as multipotent therapeutic antioxidant enzyme: Role in human diseases
- Author
-
Sunil Kumar Khare, Priyanka Saxena, Kanagarethinam Selvaraj, and Nidhee Chaudhary
- Subjects
Cell signaling ,Antioxidant ,medicine.medical_treatment ,Arthritis ,Bioengineering ,Pharmacology ,Applied Microbiology and Biotechnology ,Antioxidants ,Superoxide dismutase ,Neoplasms ,Humans ,Medicine ,chemistry.chemical_classification ,Reactive oxygen species ,biology ,Superoxide Dismutase ,business.industry ,Mechanism (biology) ,Neurodegenerative Diseases ,General Medicine ,medicine.disease ,Enzyme ,Mechanism of action ,chemistry ,biology.protein ,medicine.symptom ,Reactive Oxygen Species ,business ,Biotechnology - Abstract
Reactive oxygen species (ROS) is consistently recognized as a threat to living organisms, especially for human beings. For proper working of cellular signaling, functioning, and survival, a strict and balanced level of ROS is necessary. Superoxide dismutase (SOD); a group of metalloenzymes provides an important antioxidant defense mechanism, required to preserve the level of ROS in the body. The enzyme reveals the therapeutic potential against various diseases due to a deficiency in the ROS level. The review illustrates the numerous clinical aspects of SOD in various physiological and pathological conditions such as cancer, diabetes, arthritis, cardiovascular, neurodegenerative diseases, etc., with the mechanism of action. Despite limitations, the SOD enzyme has proved as a powerful tool against diseases, and various forms of conjugates and mimetics have been developed and reported to make it more efficient. Extensive studies need in this direction for use of natural SOD-based therapeutics for the prevention and cure of diseases.
- Published
- 2021
25. Experiential modulation of social dominance in a SYNGAP1 rat model of Autism Spectrum Disorders
- Author
-
Emma Harris, Richard G. M. Morris, Honor Myers, Kapil Saxena, Rufus Mitchell-Heggs, Peter C. Kind, and Shona Chattarji
- Subjects
Male ,Genotype ,Autism Spectrum Disorder ,General Neuroscience ,Mutant ,Neurogenetics ,SYNGAP1 ,Biology ,medicine.disease ,Phenotype ,Rats ,Dominance (ethology) ,Social Dominance ,Social neuroscience ,medicine ,Animals ,Autism ,Social Behavior ,Neuroscience - Abstract
Advances in the understanding of developmental brain disorders such as autism spectrum disorders (ASDs) are being achieved through human neurogenetics such as, for example, identifying de novo mutations in SYNGAP1 as one relatively common cause of ASD. A recently developed rat line lacking the calcium/lipid binding (C2) and GTPase activation protein (GAP) domain may further help uncover the neurobiological basis of deficits in children with ASD. This study focused on social dominance in the tube test using Syngap+/Δ-GAP (rats heterozygous for the C2/GAP domain deletion) as alterations in social behaviour are a key facet of the human phenotype. Male animals of this line living together formed a stable intra-cage hierarchy, but they were submissive when living with wild-type (WT) cage-mates, thereby modelling the social withdrawal seen in ASD. The study includes a detailed analysis of specific behaviours expressed in social interactions by WT and mutant animals, including the observation that when the Syngap+/Δ-GAP mutants that had been living together had separate dominance encounters with WT animals from other cages, the two higher ranking Syngap+/Δ-GAP rats remained dominant whereas the two lower ranking mutants were still submissive. Although only observed in a small subset of animals, these findings support earlier observations with a rat model of Fragile X, indicating that their experience of winning or losing dominance encounters has a lasting influence on subsequent encounters with others. Our results highlight and model that even with single-gene mutations, dominance phenotypes reflect an interaction between genotypic and environmental factors.
- Published
- 2021
26. Inlay total shoulder arthroplasty for primary glenohumeral arthritis
- Author
-
Anshul Saxena, John W. Uribe, Luis Vargas, David A. Porter, and John E. Zvijac
- Subjects
musculoskeletal diseases ,medicine.medical_specialty ,Shoulder ,Visual analogue scale ,medicine.medical_treatment ,Periprosthetic ,Osteoarthritis ,Diseases of the musculoskeletal system ,non-spherical humeral head ,Shoulder arthritis ,Medicine ,Orthopedics and Sports Medicine ,glenohumeral arthritis ,inlay glenoid ,Orthopedic surgery ,business.industry ,Minimal clinically important difference ,substantial clinical benefit ,minimal clinically important difference ,medicine.disease ,Arthroplasty ,Shoulder Arthroplasty ,Surgery ,Anatomic total shoulder arthroplasty ,RC925-935 ,business ,Range of motion ,Shoulder replacement ,RD701-811 - Abstract
Background: Anatomic total shoulder arthroplasty with a nonspherical humeral head and inlay glenoid replacement has been introduced in the past; however, clinical evidence remains limited. We hypothesized that patients with advanced glenohumeral arthritis demonstrate significant improvements in pain and function. Methods: Prospective patient-reported outcomes (PROs) included the American Shoulder and Elbow Surgeons score, a pain visual analog scale, and satisfaction. Range of motion was compared to the preoperative status. A sensitivity analysis examined responder rates and compared them to literature thresholds using the minimal clinically important difference and substantial clinical benefit. The preoperative glenoid morphology was determined using the Walsh classification. Zone-specific periprosthetic radiolucent lines were quantified at the last follow-up. Results: Thirty-nine shoulders in 36 patients (3 bilateral) with a mean age of 65.9 years (26 males, 13 females) and a mean follow-up of 41.0 months were included. Ninety-three percent had grade III osteoarthritis, and 7% grade II. The glenoid Walsh classification included A1 (25%), A2 (25%), B1 (22%), B2 (25%), and C (3%). All PROs improved significantly (P
- Published
- 2021
27. Prevalence of Developmental Dental Anomalies of Number and Size in Indian Population According to Age and Gender
- Author
-
Sandhya Jain, Ajay Parihar, Ashish Saxena, Amit Rawat, and Arvind Jain
- Subjects
Numeral anomaly ,Population ,Orthodontics ,Size anomaly ,Microdontia ,medicine ,Supernumerary ,education ,education.field_of_study ,business.industry ,Hypodontia ,Incidence (epidemiology) ,Hyperdontia ,Retrospective cohort study ,medicine.disease ,Anomaly ,stomatognathic diseases ,Pediatrics, Perinatology and Child Health ,Etiology ,Periodontics ,Developmental dental anomalies ,Oral Surgery ,business ,Research Article ,Demography - Abstract
Introduction Dental anomalies arise due to genetic and environmental factors in the morphodifferentiation stage of odontogenesis lead to alteration in the number and size of the tooth as well as the root.1–3 The knowledge of their prevalence and the extent of involvement can provide valuable information for phylogenic and genetic studies and also help in the understanding of differences among the population and between various population groups.4 We aim to identify the prevalence and distribution of such anomalies according to age and gender. The acquired details of cases will further help the dental clinicians to understand their etiology which can further facilitate their diagnosis and effective management. Also, timely intervention can be achieved. Materials and methods Retrospective study of 4,000 subjects (equal proportion of males and female) of age range from 10 to 40 years were studied. Their radiographs, dental casts, and clinical findings were evaluated for number and size developmental dental anomaly. Results Incidence of overall 331 cases (8.27%) of number and size developmental dental anomalies were recorded with 173 (8.6%) males and 158 (7.9%) females. Hypodontia was the most frequently found dental anomaly in both males (4.9%) and females (4.4%) followed by hyperdontia and supernumerary roots. Microdontia was the most frequently found size anomaly in both males (1.6%) and females (1.9%). Conclusion Hypodontia (4.7%) is the most frequently found numeral anomaly in both males and females. Intergroup study shows a significant statistical difference in cases of hypodontia in the 10–25 years of age-group (6.2%) with a p value ≤ 0.00001. How to cite this article Jain A, Saxena A, Jain S, et al. Prevalence of Developmental Dental Anomalies of Number and Size in Indian Population According to Age and Gender. Int J Clin Pediatr Dent 2021;14(4):531–536.
- Published
- 2021
28. Measurement Extraction using Fuzzy Set Rule for Segmented Features of Brain Tumor in T-1 & T-2 Weighted Images
- Author
-
Manini Singh and Vineeta Saxena Nigam
- Subjects
business.industry ,Computer science ,Extraction (chemistry) ,Fuzzy set ,Brain tumor ,medicine ,Pattern recognition ,Artificial intelligence ,business ,medicine.disease - Abstract
Aims: For neuro radiologist it becomes hard to accumulate features with minute dissimilarity in plenty of cases, so it is hard to make a correct decision. Therefore, the need is to generate some rules for prediction of degree of malignancy in tumors. Design: The pre-operative analysis of brain lesion is based on magnetic resonance imaging and clinical data set. Analysis of MRI finding and medical data set gives the relationship between regular pattern & interpretable pattern to acquire desired degree of malignancy. Until now the edge detection, segmentation and morphological operators are used to detect exact location of brain tumor. As uncertainty exits; here fuzzy set rules are evaluated to predict the degree by which a benign tumor is converted into malignant tumor. Methods: Fuzzy extraction theory has been applied along with image progressing algorithms like edge detection; segmentation and morphological operation based on spectral transformation are used to detect exact location of brain tumor to predict the degree malignancy. Step of Image analysis: a) Preprocessing: input 2D gif or tiff image b) Filtering of image using Anisodiff filter c) Thresholding, applying morphological operators and tumor line detection. Statistical Analysis used: A diagnostic feature includes blood flow, mass effect, temperature, calcification, edema, signal intensity & so on. Numerous features can be taken into consideration for better outcome. Results: Fuzzy set rule is one of the promising methods along with MR finding to achieve accuracy higher than 85% by considering few of the medical symptoms on different features. Conclusions: This research is limited to specific region and type of glioma and thus cannot deal heterogeneous cases in which situation is much complicated. The result evaluated here are usually retroactive. As studied, by analyzing signal intensity of T-1 & T-2 weighted image alone, accuracy of 60-70% has been achieved. So in order to get higher accuracy feature like cyst generation, oedema, blood supply are included to achieve 85% accuracy.
- Published
- 2021
29. Evaluation of the Efficacy of Coenzyme Q10 in the Management of Chronic Periodontitis: A Clinical Study
- Author
-
Sanjeev Jain, Gaurav Pandav, Sakshi Pandav, Prerna Gulati, Ridhi Aggarwal, and Divya Saxena
- Subjects
Coenzyme Q10 ,Wilcoxon signed-rank test ,business.industry ,Significant difference ,Group ii ,Bleeding on probing ,Dentistry ,medicine.disease ,Chronic periodontitis ,Clinical study ,chemistry.chemical_compound ,Scaling and root planing ,chemistry ,Medicine ,medicine.symptom ,business - Abstract
Aim The present study was aimed to clinically evaluate the effectiveness of coenzyme Q10 (CoQ10) in the management of chronic periodontitis. Materials and Methods A total of 60 patients aged between 30 and 60 years with bleeding on probing and probing pocket depth (PPD) of 3 to 5 mm were selected and divided into three groups, with group I receiving scaling and root planing, group II CoQ10 formulation for 6 weeks, and group III receiving both scaling and root planning, followed by coenzyme Q10 administration for 6 weeks. PPD, relative attachment level (RAL), and gingival index were recorded in all the groups at baseline, 6 weeks, and 3 months, respectively. The data was statistically analyzed using Kruskal–Wallis, Mann–Whitney, and Wilcoxon signed rank tests. Result Intragroup comparison showed statistically significant difference (p ≤ 0.05) between the clinical parameters of all the groups at all time intervals, whereas intergroup comparison of all the parameters showed high statistically significant difference (p ≤ 0.001) in group III at various time intervals followed by group I and group II. Conclusion It was concluded from the study that CoQ10 is a useful adjunct in treating chronic periodontitis by boosting the host resistance to periodontal disease.
- Published
- 2021
30. Imaging of Tuberculosis in Children
- Author
-
Pratyaksha Rana, Akshay Kumar Saxena, Kushaljit Singh Sodhi, and Anmol Bhatia
- Subjects
Pediatrics ,medicine.medical_specialty ,Tuberculosis ,business.industry ,medicine ,General Medicine ,medicine.disease ,business - Published
- 2021
31. Serological and Molecular Screening of Camels for Brucellosis in Bikaner, Rajasthan, India
- Author
-
Rajni Joshi, Salauddin Qureshi, and Neharika Saxena
- Subjects
endocrine system ,Psychiatry and Mental health ,Veterinary medicine ,Molecular screening ,medicine ,Brucellosis ,Biology ,medicine.disease ,Serology - Abstract
Brucellosis is an important zoonotic disease affecting domestic animals and humans worldwide. The present study was undertaken on camels in and around Bikaner city of Rajasthan state of India to assess the extent of prevalence of Brucellosis in camels in this region. Since Rose Bengal Plate test (RBPT) is a serological screening method for diagnosis of Brucellosis approved by the Office International des Epizooties (OIE), RBPT was employed for detecting antibodies against Brucella organisms in camels. Polymerase Chain Reaction is widely followed for molecular diagnosis of several infectious diseases. DNA from whole blood of camels was analyzed by PCR for detection of Brucella organisms in the blood of camels. Blood samples from 177 camels (108 males and 69 females) from Bikaner and nearby villages were analyzed for Brucellosis by RBPT. Fifteen camels [7 (46.66%) males and 8 (53.33%) females] were found positive. However, none of the DNA samples from whole blood (RBPT positive or negative) from 25 camels tested was Brucella positive by PCR. The serological results indicate that Brucellosis is prevalent in camels and is of public health significance in Bikaner and nearby villages in Rajasthan state of India. However, detection of DNA of Brucella organisms in blood by PCR may not be advised for regular screening for Brucellosis since there is intermittent bacteremia in Brucellosis and Brucella DNA may not be detectable in blood continuously throughout the course of the disease. This reminds us that the OIE has approved RBPT, but not PCR for screening of Brucellosis.
- Published
- 2021
32. Integrated oxygen therapy consisting of non invasive ventilation and nasal cannulae in respiratory failure secondary to COVID-19 pneumonia: Case series
- Author
-
Suman Choudhary, Ashok Kumar Saxena, and Anshul Singh
- Subjects
business.industry ,medicine.medical_treatment ,Hypoxia (medical) ,medicine.disease_cause ,medicine.disease ,Work of breathing ,Pneumonia ,Respiratory failure ,Oxygen therapy ,Anesthesia ,medicine ,Intubation ,Airway management ,medicine.symptom ,business ,Nasal cannula - Abstract
Patients with moderate to severe COVID-19 disease develop hypoxemic respiratory failure demonstrating profound degrees of hypoxia with little or no distress. This has put the conventional management consisting of an early intubation in question. In this case series, we attempted an integrated oxygen strategy utilizing non invasive ventilation with standard oxygen therapy (SO) via nasal cannula. We managed both the patients with successful outcomes, without the need of intubation. Hence, integrated oxygen therapy was successfully utilized for the ventilatory management of moderate to severe COVID-19 patients by improving oxygenation, making patients more comfortable and reducing the work of breathing. By complete avoidance of intubation, this technique might help in preservation of much-needed critical care ventilators and help improve patient outcomes in the areas hit hard by the pandemic. Keywords: COVID -19, Non invasive venitaltion, Nasal cannula.
- Published
- 2021
33. An Unusual Tumor in an Uncommon Site-Orbital Rosai–Dorfman Disease: A Case Report
- Author
-
Sreerekha Jinkala, Akshat Kushwaha, Sunil Kumar Saxena, Rashmi Hansdah, and Arun Alexander
- Subjects
medicine.medical_specialty ,Exacerbation ,business.industry ,Sinus Histiocytosis with Massive Lymphadenopathy ,Disease ,medicine.disease ,Dermatology ,Otorhinolaryngology ,Cervical lymphadenopathy ,medicine ,Etiology ,Surgery ,Presentation (obstetrics) ,medicine.symptom ,business ,Rosai–Dorfman disease ,Histiocyte - Abstract
Rosai–Dorfman disease (RDD) is also known as Sinus Histiocytosis with Massive Lymphadenopathy. It is a rare, benign, self-limiting disease of phagocytic histiocytes presenting with massive painless cervical lymphadenopathy. RDD can present as a nodal disease and also extra-nodal involvement with episodes of exacerbation and remissions and relapses after treatment. Its etiology remains poorly understood and is highly variable in its clinical presentation and response to treatment. Its treatment is poorly defined but the prognosis is usually fair. Here we are reporting a rare, unusual clinical presentation of infraorbital soft tissue mass diagnosed as RDD with cyto-histopathological correlation. Only a few such cases have been reported in the literature.
- Published
- 2021
34. Migrated Foreign Body of Upper Digestive Tract—A Ten-Year Institutional Experience
- Author
-
Raghul Sekar, Arun Alexander, Kalaiarasi Raja, Sunil Kumar Saxena, and Sivaraman Ganesan
- Subjects
medicine.medical_specialty ,business.industry ,Impaction ,General surgery ,Radiography ,medicine.disease ,Dysphagia ,Otorhinolaryngology ,Radiological weapon ,medicine ,Surgery ,medicine.symptom ,Foreign body ,Presentation (obstetrics) ,business ,Odynophagia - Abstract
The ingested foreign body is one of the commonest emergencies encountered by otolaryngologists Depending on the shape and duration of impaction, a small number of foreign bodies (1–2%) can perforate the wall of the gastrointestinal Tract. A migrated foreign body may remain quiescent or cause life-threatening suppurative and vascular complications. Data were collected retrospectively from the hospital records in a tertiary care hospital in South India from 2010 to 2020. Fifteen patients diagnosed with migrated foreign body and who underwent neck exploration were included in the study. Demographic details, mode of presentation, clinical and radiological findings, rigid esophagoscopy findings, neck exploration techniques employed were noted. The mean age of the patients was 37.66 years. All patients had a history of dysphagia, odynophagia, and point tenderness. All the patients underwent a lateral neck radiograph, and it was positive in 12 patients (80%), while in 3 patients (20%), it was negative. All the patients had a positive finding in Contrast-Enhanced Computed Tomography. Esophagoscopy was done prior to neck exploration to identify the site of injury and the probable site of migration. All the patients underwent lateral neck exploration, and foreign body was removed. Migrated foreign body can cause significant morbidity and mortality if not diagnosed and managed early. Strong suspicion and a systematic approach are needed for the diagnosis and management.
- Published
- 2021
35. Endoscopic ultrasound‐guided gallbladder and bile duct drainage with lumen apposing metal stent: A large multicenter cohort (with videos)
- Author
-
Sujievvan Chandran, Milan S. Bassan, Rhys Vaughan, Anton Rajadurai, Bronte A. Holt, Marios Efthymiou, Peter Tagkalidis, Anzec, Rees Cameron, Saurabh Gupta, Payal Saxena, Daniel Croagh, Leonardo Zorron Cheng Tao Pu, and Michael P. Swan
- Subjects
Endoscopic ultrasound ,medicine.medical_specialty ,medicine.medical_treatment ,Lumen (anatomy) ,medicine ,Humans ,Ultrasonography, Interventional ,Retrospective Studies ,Endoscopic retrograde cholangiopancreatography ,Hepatology ,medicine.diagnostic_test ,business.industry ,Gallbladder ,Gold standard ,Gastroenterology ,Stent ,medicine.disease ,digestive system diseases ,Surgery ,Treatment Outcome ,medicine.anatomical_structure ,Cholecystitis ,Drainage ,Stents ,Cholecystectomy ,Bile Ducts ,business - Abstract
BACKGROUND AND AIM Cholecystectomy and endoscopic retrograde cholangiopancreatography are the gold standard for managing acute cholecystitis and malignant biliary obstruction, respectively. Recent advances in therapeutic endoscopic ultrasound (EUS) have provided alternatives for managing patients in whom these approaches fail, namely, EUS-guided gallbladder drainage (EUS-GB) and EUS-guided bile duct drainage (EUS-BD). We aimed to assess the technical and clinical success of these techniques in the largest multicenter cohort published to date. METHODS A retrospective, multicenter, observational study involving 17 centers across Australia and New Zealand was conducted. All patients who had EUS-GB or EUS-BD performed in a participating center using a lumen apposing metal stent between 2016 and 2020 were included. Primary outcome was technical success, defined as intra-procedural successful drainage. Secondary outcomes included clinical success and 30-day mortality. RESULTS One hundred and fifteen patients underwent EUS-GB (n = 49) or EUS-BD (n = 66). EUS-GB was technically successful in 47 (95.9%) while EUS-BD was successful in 60 (90.9%). All failed cases were due to maldeployment of the distal flange outside of the targeted lumen. Clinical success of EUS-GB was achieved in 39 (79.6%). No patients required subsequent cholecystectomy. Clinical success of EUS-BD was achieved in 52 (78.8 %). Thirty-day mortality was 14.3% for EUS-GB and 12.1% for EUS-BD. CONCLUSIONS EUS-guided gallbladder drainage and EUS-BD are promising alternatives for managing nonsurgical candidates with cholecystitis and malignant biliary obstruction following failed endoscopic retrograde pancreatography. Both techniques delivered high technical success with acceptable clinical success. Further research is needed to investigate the gap between technical and clinical success.
- Published
- 2021
36. A Detailed Biological Approach on Hormonal Imbalance Causing Depression in Critical Periods (Postpartum, Postmenopausal and Perimenopausal Depression) in Adult Women
- Author
-
Yogendra Pal, Rashmi Saxena Pal, Nikita Saraswat, Pranay Wal, Ankita Wal, and Tamsheel Fatima Roohi
- Subjects
Postpartum depression ,medicine.medical_specialty ,Hormonal imbalance ,Obstetrics ,business.industry ,medicine.disease ,General Biochemistry, Genetics and Molecular Biology ,Adult women ,Etiology ,medicine ,Postmenopausal depression ,General Agricultural and Biological Sciences ,business ,Depression (differential diagnoses) - Abstract
Background:In today's global world, most women are experiencing midlife health problems which can affect their lives and mental status. Most of the diseases occurr after childbirth and during pregnancy or gestation period which can lead to severe problems such as postpartum depression (PPD), postmenopausal depression, perimenopausal depression which ultimately affects the mental health condition and develop various depressive episodes which ultimately lead to depression in women.Objective:The review paper gives the information that if there is untreated maternal depression then it can lead to anxiety, fear, negative effect on child development, disruption of the mother-infant relationship, and the occurrence of depressive symptoms in the early life of infants. Hormone levels are changed at the time of pregnancy.Methods:The data was collected by studying combination of research and review papers from different databases like PubMed, Medline, and Web of science by using search keywords like “Postpartum depression”, “Postmenopausal depression”, “Risk factors”, “Pathogenesis of PPD”, “Predictors of postpartum depression”.Results:This can lead to disrupting the quality of life of menopausal women like deficiency of nutrients, not properly regular physical activities, elevated Body Mass Index (BMI), loss of libido (loss of interest in sexual activities), due to the lack of education, and awareness among the people. Factors like increase in physical activity can naturally help in PPD condition. Mind body therapy, drug therapy and cognitive and mindfulness-based therapies help in hormonal imbalances.Conclusion:It was found that low birth weight and congenital abnormalities in babies lead to affect depression after delivery. It is recommended that health care providers and physicians are provided with information regarding factors contributing PPD and postmenopausal depression. Sleep timings and consumptions of nutraceuticals can help in natural healing with depression amongst women suffering from postpartum, postmenopausal and perimenopausal depression.
- Published
- 2021
37. Impact of the COVID-19 pandemic on adolescent vaccinations: projected time to reverse deficits in routine adolescent vaccination in the United States
- Author
-
Andres Gomez-Lievano, Ya-Ting Chen, Cristina Carias, Jessica R. Marden, Oscar Patterson-Lomba, Lixia Yao, Kunal Saxena, and Alexandra Bhatti
- Subjects
Pediatrics ,medicine.medical_specialty ,Adolescent ,Coronavirus disease 2019 (COVID-19) ,SARS-CoV-2 ,Tetanus ,business.industry ,Diphtheria ,Vaccination ,COVID-19 ,General Medicine ,HPV vaccines ,Diphtheria-Tetanus-acellular Pertussis Vaccines ,medicine.disease ,United States ,Adolescent vaccination ,Pandemic ,medicine ,Humans ,Papillomavirus Vaccines ,business ,Pandemics ,Immunization Schedule ,Acellular pertussis - Abstract
OBJECTIVE: The COVID-19 pandemic has led to significant reductions in the administration of routinely recommended vaccines among adolescents in the US including tetanus, diphtheria, and acellular pertussis (Tdap); meningococcal (ACWY); and human papillomavirus (HPV) vaccines. The extent to which these deficits could persist in 2021 and beyond is unclear. To address this knowledge gap, this study estimated the cumulative deficits of routine vaccine doses among US adolescents during the COVID-19 pandemic and estimated the time and effort needed to recover from those deficits. METHODS: Monthly reductions in Tdap, meningococcal, and HPV doses administered to US adolescents during the COVID-19 pandemic were quantified using MarketScan Commercial Claims and Encounters data. The time and effort required to reverse the vaccination deficit under various catch-up scenarios were estimated. RESULTS: Annual doses administered of Tdap, meningococcus, and HPV vaccines decreased by 21.2%, 20.8%, and 24.0%, respectively, in 2020 compared to 2019. For 2021, the reduction in doses administered is projected to be 6%-21% compared to 2019 under different scenarios. The projected deficit of missed doses is expected to be cleared between winter 2023 and fall 2031. CONCLUSIONS: Administration rates of routine vaccines decreased significantly among US adolescents during COVID-19. Reversing these deficits to mitigate long-term health and economic consequences will require a sustained increase in vaccination rates over multiple years.
- Published
- 2021
38. Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian Population
- Author
-
Balram Bhargava, Anita Saxena, Raghav Bansal, Milind Padmakar Hote, Kartik Gupta, Avinainder Singh, Gautam Sharma, Ruma Ray, Aayush K. Singal, Chetan Patel, Velayoudam Devagourou, Ujjwal K. Chowdhury, Ganesan Karthikeyan, Sharmila Dorbala, Sundeep Mishra, Akshay Kumar Bisoi, Sivasubramanian Ramakrishnan, Sudheer Kumar Arawa, and Palleti Rajashekar
- Subjects
medicine.medical_specialty ,biology ,business.industry ,Amyloidosis ,Indian population ,macromolecular substances ,medicine.disease ,EMB - Endomyocardial biopsy ,Transthyretin ,Stenosis ,Oncology ,Cardiac amyloidosis ,Internal medicine ,Concomitant ,cardiovascular system ,medicine ,biology.protein ,Cardiology ,TAVR -transcatheter aortic valve replacement ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background Prevalence of both degenerative severe aortic stenosis (AS) and transthyretin cardiac amyloidosis (ATTR-CA) increases with age. Dual disease (AS+myocardial ATTR-CA) occurs in si...
- Published
- 2021
39. The impact of mosquito proof lids of underground tanks 'tanka' on the breeding of Anopheles stephensi in a village in western Rajasthan, India
- Author
-
Amit Sharma, Sanjeev Kumar Gupta, Rekha Saxena, Kumar Vikram, and Himmat Singh
- Subjects
Irrigation ,Population ,RC955-962 ,India ,Mosquito Vectors ,Infectious and parasitic diseases ,RC109-216 ,Rainwater harvesting ,Water Supply ,Surveys and Questionnaires ,Arctic medicine. Tropical medicine ,Anopheles ,parasitic diseases ,medicine ,Animals ,Humans ,Socioeconomics ,education ,Anopheles stephensi ,Western Rajasthan ,education.field_of_study ,biology ,Desert climate ,Research ,medicine.disease ,biology.organism_classification ,Housing, Animal ,Malaria ,Infectious Diseases ,Geography ,Vector (epidemiology) ,Housing ,Parasitology ,Desert Climate ,Tankas - Abstract
Background Western Rajasthan in India has a typical desert climate. Until the introduction of the canal water irrigation system, malaria was an unstable and seasonal occurrence. Due to the scarcity of water, the community practised having one large underground tank (locally known as the tanka) in their house to collect rainwater for long-term household use. Anopheles stephensi, one of the major malaria vectors, breeds in improperly covered "tankas” if not properly covered and harbours a vector population throughout the year. Methods Two villages, Ajasar (intervention) and Tota (control), with similar ecological features, were selected for the study. A pre-intervention survey was carried out in both villages to assess the presence and quality of lids of tankas, and mosquito breeding and adult mosquito density. Awareness of the community about malaria and mosquitoes was also assessed during the pre-intervention period. In the intervention village, damaged or improper lids were replaced with improved mosquito proof polyvinyl chloride plastic (PVC) lids and lasted longer than the conventional lids. The fitness of the lids was assessed one year after the pre-intervention survey. The entomological assessment was carried out in both intervention and non-intervention villages. The level of community awareness about malaria, mosquitoes, their breeding places, and the role of tankas in malaria transmission was assessed both during pre- and post-intervention. Results During the pre-intervention survey,Anopheles breeding was found in 22.1% (58/262) of tankas in the intervention village and 27.1% (19/70) in tankas in the control village. Mosquito breeding was observed in the tankas with iron lids in the intervention village (48.3%) and the control village (42.1%). In the intervention village, out of 262 tankas in the village, 200 lids were replaced, resulting in the complete absence of mosquito breeding. In the pre-intervention survey conducted in May 2018, Anopheles stephensi consisted of 46% of adult mosquitoes in the intervention village and 55% in the control village. Its density was significantly reduced to 0.55 per man-hour (94.95%) and 0.22 per man-hour (97.8%) in the post-intervention survey in June 2018 and a follow-up survey in May 2019, respectively, in the intervention village. Discussion The density of Anopheles stephensi adults was reduced significantly (97.8%) in the intervention village due to complete prevention of breeding in the underground tankas in the intervention village as compared to the control with no density reduction. The awareness level of the community was also improved due to their involvement in the study. Conclusion Provision of proper metal lids or replacement of damaged lids on underground water storage tanks as an environmental management approach prevented the breeding of the malaria vector, Anopheles stephensi, in a desert village in western Rajasthan.
- Published
- 2021
40. Prenatal Pericardiocentesis and Postnatal Sirolimus for a Giant Inoperable Cardiac Rhabdomyoma
- Author
-
DM Vineeta Ojha, P. Chaudhary, DM Jay Relan, Manish Swami, Vatsla Dadhwal, Sowmya Devarapalli, Priya Jagia, DM Anita Saxena, Ankit Verma, and A. Rana
- Subjects
medicine.medical_specialty ,cardiac tumor ,mTOR inhibitor ,medicine.medical_treatment ,Case Report ,tuberous sclerosis ,mTOR, mammalian target of rapamycin ,fetal cardiac MRI ,Tuberous sclerosis ,TS, tuberous sclerosis ,Fetal rhabdomyoma ,Internal medicine ,fetal rhabdomyoma ,medicine ,Heart Care Team/Multidisciplinary Team Live ,LV, left ventricular ,Cardiac Tumors ,Fetus ,business.industry ,Cardiac rhabdomyoma ,PE, pericardial effusion ,Cardiorespiratory fitness ,medicine.disease ,Pericardiocentesis ,Sirolimus ,Cardiology ,PGE1, prostaglandin E1 ,Cardiology and Cardiovascular Medicine ,business ,medicine.drug - Abstract
We describe the case of an antenatally diagnosed massive cardiac tumor in a fetus requiring cardiorespiratory support immediately following birth. We further discuss the successful management of this case and highlight the importance of a multidisciplinary team in managing such complicated cases. (Level of Difficulty: Advanced.), Central Illustration
- Published
- 2021
41. AI-Enabled Support System for Melanoma Detection and Classification
- Author
-
Vivek Sen Saxena, Avneesh Kumar, and Prashant Johri
- Subjects
Leadership and Management ,business.industry ,Computer science ,Melanoma ,Feature extraction ,Health Informatics ,Pattern recognition ,Image segmentation ,medicine.disease ,Computer Science Applications ,Melanoma detection ,Lesion ,Support vector machine ,Medical Laboratory Technology ,GrabCut ,Health Information Management ,medicine ,Artificial intelligence ,Noise (video) ,medicine.symptom ,business - Abstract
Skin lesion melanoma is the deadliest type of cancer. Artificial intelligence provides the power to classify skin lesions as melanoma and non-melanoma. The proposed system for melanoma detection and classification involves four steps: pre-processing, resizing all the images, removing noise and hair from dermoscopic images; image segmentation, identifying the lesion area; feature extraction, extracting features from segmented lesion and classification; and categorizing lesion as malignant (melanoma) and benign (non-melanoma). Modified GrabCut algorithm is employed to generate skin lesion. Segmented lesions are classified using machine learning algorithms such as SVM, k-NN, ANN, and logistic regression and evaluated on performance metrics like accuracy, sensitivity, and specificity. Results are compared with existing systems and achieved higher similarity index and accuracy.
- Published
- 2021
42. Thiamine increases resident endoglin positive cardiac progenitor cells and atrial contractile force in humans: A randomised controlled trial
- Author
-
Richard W. Bunton, Eng Leng Saw, Aram A. Babakr, Sean Coffey, Rajesh Katare, Parul Dixit, Ivor F. Galvin, Philip Davis, Michael J.A. Williams, Pankaj Saxena, Isabelle van Hout, and Regis R. Lamberts
- Subjects
medicine.medical_specialty ,business.industry ,Stem Cells ,Endoglin ,CD34 ,medicine.disease ,Coronary artery bypass surgery ,Internal medicine ,Heart failure ,medicine ,Cardiology ,Clinical endpoint ,Humans ,Thiamine ,Heart Atria ,Stem cell ,Progenitor cell ,Cardiology and Cardiovascular Medicine ,business ,Aged ,Signal Transduction - Abstract
Background The heart has an intrinsic ability to regenerate, orchestrated by progenitor or stem cells. However, the relative complexity of non-resident cardiac progenitor cell (CPC) therapy makes modulation of resident CPCs a more attractive treatment target. Thiamine analogues improve resident CPC function in pre-clinical models. In this double blinded randomised controlled trial (identifier: ACTRN12614000755639), we examined whether thiamine would improve CPC function in humans. Methods and results High dose oral thiamine (one gram twice daily) or matching placebo was administered 3–5 days prior to coronary artery bypass surgery (CABG). Right atrial appendages were collected at the time of CABG, and CPCs isolated. There was no difference in the primary outcome (proliferation ability of CPCs) between treatment groups. Older age was not associated with decreased proliferation ability. In exploratory analyses, isolated CPCs in the thiamine group showed an increase in the proportion of CD34−/CD105+ (endoglin) cells, but no difference in CD34−/CD90+ or CD34+ cells. Thiamine increased maximum force developed by isolated trabeculae, with no difference in relaxation time or beta-adrenergic responsiveness. Conclusion Thiamine does not improve proliferation ability of CPC in patients undergoing CABG, but increases the proportion of CD34−/CD105+ cells. Having not met its primary endpoint, this study provides the impetus to re-examine CPC biology prior to any clinical outcome-based trial examining potential beneficial cardiovascular effects of thiamine.
- Published
- 2021
43. Evaluation and Management of First-Time Seizure in Adults
- Author
-
Aneeta Saxena, Myriam Abdennadher, and Milena Pavlova
- Subjects
Adult ,Pediatrics ,medicine.medical_specialty ,Epilepsy ,medicine.diagnostic_test ,business.industry ,Brain ,Electroencephalography ,Physical examination ,Symptomatic seizures ,Disease ,medicine.disease ,Review article ,Neurology ,Neuroimaging ,Recurrence ,Seizures ,medicine ,Etiology ,Humans ,Anticonvulsants ,Neurology (clinical) ,business - Abstract
First seizures are often perceived as devastating events by patients and their families due to the fear of having a life-long disease. One in 10 people experiences one or more seizures during their lifetime, while 1 in 26 people develops epilepsy. Acute symptomatic seizures are often related to a provoking factor or an acute brain insult and typically do not recur. Careful history and clinical examination should guide clinicians' management plans. Electroencephalography and brain imaging, preferably with epilepsy-specific magnetic resonance imaging, may help characterize both etiology and risk of seizure recurrence. Antiepileptic drugs should be initiated in patients with newly diagnosed epilepsy. In patients without an epilepsy diagnosis, the decision to prescribe drugs depends on individual risk factors for seizure recurrence and possible complications from seizures, which should be discussed with the patient. Counseling about driving and lifestyle modifications should be provided early, often at the first seizure encounter.
- Published
- 2021
44. Could the System Side Knowledge towards Hepatitis B be Translated to the Demand Side: A Cross-Sectional Evaluation in Sabarkantha, Gujarat
- Author
-
Sandul Yasobant, Sushil Patel, Mayur Patel, Deepak Saxena, Yash M. Patel, and Farjana Zakir Memon
- Subjects
Demand side ,business.industry ,Medicine ,Hepatitis B ,business ,medicine.disease ,Socioeconomics - Published
- 2021
45. Association of Poor Sleep Burden in Middle Age and Older Adults With Risk for Delirium During Hospitalization
- Author
-
Frank A.J.L. Scheer, Ma Cherrysse Ulsa, Richa Saxena, Oluwaseun Akeju, Kun Hu, Martin K. Rutter, Peng Li, Xi Zheng, Patricia Wong, Lei Gao, and Arlen Gaba
- Subjects
Aged, 80 and over ,Aging ,medicine.medical_specialty ,business.industry ,Proportional hazards model ,Hazard ratio ,Delirium ,Chronotype ,Excessive daytime sleepiness ,Disorders of Excessive Somnolence ,medicine.disease ,Middle age ,Hospitalization ,Sleep Initiation and Maintenance Disorders ,Internal medicine ,Cohort ,medicine ,Humans ,Dementia ,Geriatrics and Gerontology ,medicine.symptom ,Sleep ,business ,Aged - Abstract
Background Delirium is a distressing neurocognitive disorder recently linked to sleep disturbances. However, the longitudinal relationship between sleep and delirium remains unclear. This study assessed the associations of poor sleep burden, and its trajectory, with delirium risk during hospitalization. Methods About 321 818 participants from the UK Biobank (mean age 58 ± 8 years [SD]; range 37–74 years) reported (2006–2010) sleep traits (sleep duration, excessive daytime sleepiness, insomnia-type complaints, napping, and chronotype—a closely related circadian measure for sleep timing), aggregated into a sleep burden score (0–9). New-onset delirium (n = 4 775) was obtained from hospitalization records during a 12-year median follow-up. About 42 291 (mean age 64 ± 8 years; range 44–83 years) had repeat sleep assessment on average 8 years after their first. Results In the baseline cohort, Cox proportional hazards models showed that moderate (aggregate scores = 4–5) and severe (scores = 6–9) poor sleep burden groups were 18% (hazard ratio = 1.18 [95% confidence interval: 1.08–1.28], p < .001) and 57% (1.57 [1.38–1.80], p < .001), more likely to develop delirium, respectively. The latter risk magnitude is equivalent to 2 additional cardiovascular risks. These findings appeared robust when restricted to postoperative delirium and after exclusion of underlying dementia. Higher sleep burden was also associated with delirium in the follow-up cohort. Worsening sleep burden (score increase ≥2 vs no change) further increased the risk for delirium (1.79 [1.23–2.62], p = .002) independent of their baseline sleep score and time lag. The risk was highest in those younger than 65 years at baseline (p for interaction Conclusion Poor sleep burden and worsening trajectory were associated with increased risk for delirium; promotion of sleep health may be important for those at higher risk.
- Published
- 2021
46. Use of Novel Thermography Features of Extraction and Different Artificial Neural Network Algorithms in Breast Cancer Screening
- Author
-
Ritu Vijay, Pallavi Pahadiya, Kumod Kumar Gupta, and Shivani Saxena
- Subjects
Artificial neural network ,medicine.diagnostic_test ,Computer science ,Sigmoid function ,medicine.disease ,Rprop ,Computer Science Applications ,Breast cancer screening ,Breast cancer ,Thermography ,medicine ,Mammography ,Electrical and Electronic Engineering ,skin and connective tissue diseases ,Gradient descent ,Algorithm - Abstract
The breast thermography process is a physiological investigation that gives data dependent on the heat variations in the breast. It accounts for the heat circulation of a body utilizing the infrared radiation produced by the outside of that body. Precancerous tissue and the zone around a carcinogenic tumor have greater heats because of angiogenesis, and higher substance and blood vein action than a healthy breast; consequently, breast thermography can possibly recognize early strange changes in breast tissues. Thermography can identify the earliest indication of cancer initiation before mammography can notice. For the extraction of the scarce data from the breast, features like Energy, Effective information, Multi quadratic, Sigmoid, and Age of the patient are determined and applied to the neural network as inputs. Resilient backpropagation algorithm (RBPA) is a worldwide methodology managing weights; it is hard to get better subtleties from the breast image. To overcome the problems of RBPA, the artificial neural network (ANN) classifier is being used as a new derived Extension of Resilient backpropagation algorithm (ERBPA) for validation purposes. In this paper three ANN-based algorithms are used: Gradient descent, RBPA, and ERBPA are discussed and compared. As per the outcomes, the recently determined ERBPA is a progressively exact methodology to classify benign and malignant pathology. An accuracy of 99.90% has been obtained to bring about an effective strategy, which can recognize and cure breast cancer at an early stage.
- Published
- 2021
47. Recurrent Giant Mucoepidermoid Carcinoma of the Parotid: A Case Report and Review of Literature
- Author
-
Sunil Kumar Saxena, Kezevino Nagi, Raghul Sekar, Arun Alexander, and Sivaraman Ganesan
- Subjects
medicine.medical_specialty ,Salivary gland ,business.industry ,Sural nerve ,Malignancy ,medicine.disease ,Parotid gland ,Modified Radical Neck Dissection ,medicine.anatomical_structure ,Otorhinolaryngology ,Mucoepidermoid carcinoma ,medicine ,Surgery ,Radiology ,Presentation (obstetrics) ,business - Abstract
Mucoepidermoid carcinoma is the most common salivary gland malignancy and about one third occurs in the parotid gland. The peak incidence is commonly seen between the third and fifth decades of life. It routinely presents as a fixed, painless mass below the ear. However, its presentation as a giant mass is exceedingly rare. Here, we report a case of a recurrent giant exophytic mucoepidermoid carcinoma in a young male. He underwent Revision Total Parotidectomy with Modified Radical neck dissection with Sural nerve grafting and an Anterolateral thigh flap reconstruction followed by Adjuvant radiotherapy. The rarity of the clinical presentation and the management challenges faced in a young male are being discussed in this case report.
- Published
- 2021
48. Optical coherence tomography angiography in amblyopia: A critical update on current understandings and future perspectives
- Author
-
Rohan Chawla, Amar Pujari, Gunjan Saluja, Rohit Saxena, Swati Phuljhele, and Asha Samdani
- Subjects
Visual acuity ,Choroid ,business.industry ,Retinal Vessels ,Small sample ,General Medicine ,Optical coherence tomography angiography ,Diabetic retinopathy ,Macular degeneration ,Amblyopia ,medicine.disease ,eye diseases ,Ophthalmology ,medicine ,Patient profile ,Humans ,Optometry ,sense organs ,Fluorescein Angiography ,medicine.symptom ,business ,Pre and post ,Tomography, Optical Coherence ,Systematic search - Abstract
Optical coherence tomography angiography (OCTA) is a non-invasive tool to assess the retino-choroidal vasculature in vivo. It tracks the red blood cell movement and maps the vasculature in quick succession. In routine, diabetic retinopathy, age related macular degeneration, central serous chorioretinopathy, and others are commonly being studied to unveil its clinic role. On the other hand, amblyopia is a condition where the visual acuity is subnormal due to non-organic causes in the eye. But the OCTA studies till now have shown variable changes along retino-choroidal vasculature. Hence, to comprehend the existing literature knowledge, a systematic literature search was carried out and the original works describing novel findings in amblyopic eyes on OCTA were included. Upon detailed assessment, firstly, the disturbed vasculature along superficial retinal plexus, deeper retinal plexus, and choroidal plexus were evident in most untreated amblyopic eyes. However, such changes were not uniform, which is due to noted heterogenic patient profile, small sample size, biometric biases, non-uniform algorithms, and other factors. And to note, even in presence of such diverse changes, almost all the authors stated a plausible explanation for their notable changes. Secondly, the utility of OCTA in identifying vascular changes with standard treatments and segregation of visual beneficiaries from non-beneficiaries were possible. Hence, to conclude, OCTA is a valuable tool which can provide valuable useful insights into the amblyopic eyes during pre and post treatment periods. However, to gather more concrete evidence for clinical benefits, systematic, homogenous, and better structured clinical studies are mandated.
- Published
- 2021
49. Predicting Outcome in Skull Base Osteomyelitis: An Assessment of Demographic, Clinical, and Pathological Attributes
- Author
-
Gagandeep Singh, Gunchan Paul, Birinder S Paul, Archana Ahluwalia, and Alisha Saxena
- Subjects
medicine.medical_specialty ,Palsy ,business.industry ,General Neuroscience ,Osteomyelitis ,Mortality rate ,Encephalopathy ,Neurosciences. Biological psychiatry. Neuropsychiatry ,Disease ,medicine.disease ,outcomes ,mortality ,Internal medicine ,Cohort ,medicine ,risk factors ,Original Article ,Neurology (clinical) ,skull base osteomyelitis ,business ,Pathological ,Stroke ,RC321-571 - Abstract
Objective Skull base osteomyelitis (SBO) is an enigmatic clinical diagnosis which is difficult to decipher and is associated with poor outcomes. The study aims to examine the demographic and clinical characteristics of patients with SBO and its outcomes. Materials and Methods Medical records of 30 patients with diagnosis of SBO over past 5 years were assessed for demographic and clinical characteristics, type of SBO, radiological parameters, treatment received, procedure performed, microbiological profile, comorbidities, and complications including cranial nerve (CN) palsies. These factors were analyzed for prediction of outcome (death or survival). Statistical Analysis Microsoft Office Excel 2010 SAS 10.0 for Windows was used. Student's t-test for continuous variables (age, duration of symptoms, number of days of hospitalization, and treatment duration) and chi-square test for categorical variables (imaging findings, symptomatology, presence of comorbidities, surgical procedure, complications, and type of antibiotics) were utilized. Results We found SBO was the disease of elderly population (64.07 ± 6.13 years) with male predominance (83.3%) highly associated with uncontrolled diabetes status (93.3%). Headache (100%) and CN palsy (80%) were the most common neurological presenting complaints followed by stroke (17%) and encephalopathy (10%). Pathological and radiological correlation showed that fungal infection (Aspergillus) was associated with anterior SBO (10%), while bacteria (Pseudomonas) was cultured from posterior SBO (30%). Fifty per cent of patients were alive after 1 year out of which 33% had good functional outcome. The mortality rate was 33.3% in our cohort and multiple lower CN palsies (p = 0.04), suboptimal duration of medical treatment (p = 0.03), surgical intervention during clinical course (p = 0.02), and development of intracranial or extracranial complications (p = 0.03) were the predictors of mortality. Conclusion Early diagnosis including identification of pathogenic organisms and optimal duration of treatment are crucial factors for improved outcomes in SBO.
- Published
- 2021
50. Role of 99mTc sulphur colloid lymphoscintigraphy in a rare case of chylothorax and lymphocele formation post esophageal duplication cyst excision
- Author
-
Arun Prashanth, Naveen Yadav, Sameer Taywade, Rajesh Kumar, and Rahul Saxena
- Subjects
Leak ,medicine.medical_specialty ,Chyle ,Pertechnetate ,Lymphocele ,Biophysics ,R895-920 ,Case Report ,Sulphur colloid ,Chylothorax ,chemistry.chemical_compound ,Medical physics. Medical radiology. Nuclear medicine ,Computer Science (miscellaneous) ,medicine ,Filtered Tc-99m Sulphur colloid ,Radiology, Nuclear Medicine and imaging ,Cyst ,business.industry ,medicine.disease ,chemistry ,SPECT-CT ,Molecular Medicine ,Radiology ,business ,Ligation ,Lymphoscintigraphy - Abstract
We report a rare case of chylothorax with lymphocele formation post esophageal duplication cyst (EDC) excision in a 2 year old male child. Patient developed chylothorax after excision of EDC. Pleural fluid cytology showed increased triglycerides and cholesterol levels. Filtered Tc-99m Sulphur colloid lymphoscintigraphy showed abnormal radiotracer uptake in the lower thoracic region on right side corresponding to lymphocele on SPECT-CT images with possible site of leak medially. In addition, Tc-99m pertechnetate scan was done to rule out possibility of residual duplication cyst revealed no abnormality. Patient underwent open and en-masse ligation of the duct. Patient recovered completely post-surgery. This case highlights the importance of lymphoscintigraphy with SPECT-CT in the evaluation of patients with post-operative complications of chylothorax with detection of site of chyle leak.
- Published
- 2021
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.